CircDOCK7 facilitates the proliferation and adipogenic differentiation of chicken abdominal preadipocytes through the gga-miR-301b-3p/ACSL1 axis

Weihua Tian; Ye Liu; Wenhui Zhang; Ruixue Nie; Yao Ling; Bo Zhang; Hao Zhang; Changxin Wu

doi:10.1186/s40104-023-00891-8

. 2023 Jul 6;14:91. doi: 10.1186/s40104-023-00891-8

CircDOCK7 facilitates the proliferation and adipogenic differentiation of chicken abdominal preadipocytes through the gga-miR-301b-3p/ACSL1 axis

Weihua Tian ¹, Ye Liu ¹, Wenhui Zhang ¹, Ruixue Nie ¹, Yao Ling ¹, Bo Zhang ¹, Hao Zhang ^1,^✉, Changxin Wu ¹

PMCID: PMC10324207 PMID: 37408086

Abstract

Background

Abdominal fat deposition depends on both the proliferation of preadipocytes and their maturation into adipocytes, which is a well-orchestrated multistep process involving many regulatory molecules. Circular RNAs (circRNAs) have emergingly been implicated in mammalian adipogenesis. However, circRNA-mediated regulation in chicken adipogenesis remains unclear. Our previous circRNA sequencing data identified a differentially expressed novel circRNA, 8:27,886,180|27,889,657, during the adipogenic differentiation of chicken abdominal preadipocytes. This study aimed to investigate the regulatory role of circDOCK7 in the proliferation and adipogenic differentiation of chicken abdominal preadipocytes, and explore its molecular mechanisms of competing endogenous RNA underlying chicken adipogenesis.

Results

Our results showed that 8:27,886,180|27,889,657 is an exonic circRNA derived from the head-to-tail splicing of exons 19–22 of the dedicator of cytokinesis 7 (DOCK7) gene, abbreviated as circDOCK7. CircDOCK7 is mainly distributed in the cytoplasm of chicken abdominal preadipocytes and is stable because of its RNase R resistance and longer half-life. CircDOCK7 is significantly upregulated in the abdominal fat tissues of fat chickens compared to lean chickens, and its expression gradually increases during the proliferation and adipogenic differentiation of chicken abdominal preadipocytes. Functionally, the gain- and loss-of-function experiments showed that circDOCK7 promoted proliferation, G0/G1- to S-phase progression, and glucose uptake capacity of chicken abdominal preadipocytes, in parallel with adipogenic differentiation characterized by remarkably increased intracellular lipid droplet accumulation and triglyceride and acetyl coenzyme A content in differentiated chicken abdominal preadipocytes. Mechanistically, a pull-down assay and a dual-luciferase reporter assay confirmed that circDOCK7 interacted with gga-miR-301b-3p, which was identified as an inhibitor of chicken abdominal adipogenesis. Moreover, the ACSL1 gene was demonstrated to be a direct target of gga-miR-301b-3p. Chicken ACSL1 protein is localized in the endoplasmic reticulum and mitochondria of chicken abdominal preadipocytes and acts as an adipogenesis accelerator. Rescue experiments showed that circDOCK7 could counteract the inhibitory effects of gga-miR-301b-3p on ACSL1 mRNA abundance as well as the proliferation and adipogenic differentiation of chicken abdominal preadipocytes.

Conclusions

CircDOCK7 serves as a miRNA sponge that directly sequesters gga-miR-301b-3p away from the ACSL1 gene, thus augmenting adipogenesis in chickens. These findings may elucidate a new regulatory mechanism underlying abdominal fat deposition in chickens.

Supplementary Information

The online version contains supplementary material available at 10.1186/s40104-023-00891-8.

Keywords: Abdominal fat deposition, Adipogenesis, Chickens, CircDOCK7, Competing endogenous RNA, MiRNA sponge

Background

Chickens are the most economically desirable agricultural poultry worldwide because of their meat and egg production. Intensive genetic selection for body weight and growth rate in broilers and laying chickens has tremendously improved their growth performance and reduced market age but is accompanied by excessive body fat disposition, especially abdominal fat. Excessive abdominal fat deposition is one of the main problems in the poultry industry, as it not only reduces feed efficiency, carcass yield, reproductive performance, and consumer preference but also increases the difficulty in meat processing as well as nitrogen and phosphate content in the excrement, thus resulting in considerable obstacles to profitable farming and environmental pollution [1–3]. Abdominal fat weight and percentage are direct indexes of abdominal fat deposition in chickens but are not suitable for indirect in vivo measurement. Chicken abdominal fat weight and percentage have high heritability and strong positive genetic correlation, indicating that the genetic approach is the most effective way to reduce excessive abdominal fat deposition in chickens [3, 4]. Therefore, it is of great significance to determine the crucial mediators of abdominal fat deposition, and thus contribute to the genetic improvement of excessive abdominal fat in chickens and breeding of lean-line broilers.

Abdominal fat deposition depends on the proliferation (number) of preadipocytes and their maturation (size) into adipocytes, which is a precisely orchestrated process regulated by many regulatory molecules, including protein-coding genes, transcription factors, epigenetic modifiers, and non-coding RNAs (ncRNAs). Several classes of ncRNAs, such as long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), microRNAs (miRNAs), are transcribed from approximately 98% of the genomic loci in eukaryotic cells. As a widespread RNA species in eukaryotic cells, circRNAs present covalently closed continuous loop structures from the covalently joined 3′- and 5′-ends of a single-stranded RNA molecule (termed as backsplicing) during RNA splicing, without 5′–3′ polarity and a polyadenylated poly(A) tail [5]. Owing to the lack of accessible ends, circRNAs are more stable than linear RNAs and can survive exonuclease RNase R, which possesses strong 3′-exonuclease activity for linear or Y-shaped RNA degradation [6]. CircRNAs arise from exons (exonic circRNAs), introns (intronic circRNAs), or a combination of both (exon–intron circRNAs), and the subcellular localization of the three types of circRNAs often shows different compartment preferences [7]. Moreover, circRNAs are usually expressed in a developmental stage-, tissue-, and cell-specific manner [8–10]. Such diverse subcellular localizations and expression patterns suggest the complexity of the functions and regulatory mechanisms of circRNAs. General mechanisms of circRNA functions include competing endogenous RNAs (ceRNAs) that sponge miRNAs, interacting with RNA-binding protein, protein scaffolding, enhancer of protein function for gene transcription activation, competition with precursor mRNA splicing, and templates for translation to produce unique circRNA peptides [7, 11]. Although circRNAs were previously considered as the transcriptional "noise" generated by aberrant splicing events, with the development of high-throughput sequencing and continuous exploration of their diverse functions, circRNAs have been shown to play vital roles in growth and development, metabolic processes, diseases, and cancer. CircRNAs have been extensively proposed to serve as highly effective biomarkers in obesity and disease diagnosis, treatment, and prognosis, and thus have become the latest research hotspot in the RNA field [12].

Increasing evidence has revealed a few circRNAs that are functionally and mechanistically characterized in mammalian adipogenesis, such as circTshz2-1 and circArhgap5-2 [13], circSAMD4A [14], circFOXP1 [15], CDR1as [16], circH19 [17], circFLT1 [18], sus_circPAPPA2 [19], and circPPARA [20]. Intriguingly, recent studies have shown that mammalian adipocyte-expressed circRNAs also affect various other organs, including the liver and skin, via exosome, a crucial carrier mediating signal conduction between adipocytes and target organs, resulting in the transcriptomic evaluation of target organs such as circ-DB [21], circ_0075932 [22], and mmu_circ_0000623 [23]. In chickens, extremely limited investigations have been conducted on the precise roles and molecular mechanisms of circRNAs in adipogenesis, although the expressed circRNAs in abdominal adipose tissue have been authenticated. A total of 275 differentially expressed circRNAs, whose parental genes are significantly involved in lipid-related biological processes and signaling pathways, have been identified in the abdominal fat tissue of Chinese domestic Gushi chickens at 6, 14, 22, and 30 weeks of age. The ceRNA network indicated that these differentially expressed circRNAs might play endogenous competitive regulatory roles through interactions with multiple miRNAs during abdominal fat tissue development in chickens [24]. Integrative analysis of circRNA, miRNA, and mRNAs profiles during chicken intramuscular and abdominal adipogenic differentiation revealed that circLCLAT1, circFNDC3AL, circCLEC19A, and circARMH1 potentially affect intramuscular and abdominal adipogenesis by sponging miRNAs to regulate downstream genes involved in peroxisome proliferator-activated receptor (PPAR)- and fatty acid metabolism-related signaling pathways [25]. A comparative analysis of circRNA expression in abdominal fat tissues with high and low abdominal fat percentage of Guangxi Partridge chickens identified 26 differentially expressed circRNAs. Of these, novel_circ_PTPN2, novel_circ_CTNNA1, and novel_circ_PTPRD may serve as ceRNAs to regulate abdominal fat deposition [26]. In our previous study, we identified 111 differentially expressed circRNAs in chicken abdominal adipocytes at 0, 12, 48, 72, and 120 h post-differentiation, wherein Z:35,565,770|35,568,133 and Z:54,674,624|54,755,962 were considered candidate regulators of chicken adipogenic differentiation. Z:35,565,770|35,568,133 may compete with precursor mRNA splicing of its lipogenesis-related parental gene, abhydrolase domain containing 17B, depalmitoylase (ABHD17B), and Z:54,674,624|54,755,962 may function as a ceRNA that competitively sponges miRNAs to regulate the expression of lipogenesis-related genes [27]. These results imply that circRNAs might function as pivotal regulators of adipogenesis and abdominal fat deposition in chickens. Therefore, further studies are needed to reveal the multifaceted roles of circRNAs in adipogenesis and uncover the underlying molecular mechanisms in chickens.

In the present study, we identified a gradually increasing and differentially expressed circRNA, 8:27,886,180|27,889,657, based on our previously reported circRNA sequencing data during chicken abdominal preadipocyte adipogenic differentiation (accession number: PRJNA732104) [27]. The circRNA 8:27,886,180|27,889,657 is composed of exons 19–22 of the linear transcript of the dedicator of cytokinesis 7 (DOCK7) gene with a length of 654 nucleotides (abbreviated as circDOCK7). We then explored its characteristics, expression patterns, biological functions, and regulatory mechanisms, and found that circDOCK7 could promote the proliferation and adipogenic differentiation of chicken abdominal preadipocytes by serving as a miRNA sponge to directly sequester gga-miR-301b-3p away from the acyl-CoA synthetase long-chain family member 1 (ACSL1) gene and promote its expression post-transcriptionally. To our best knowledge, our study is the first to elucidate the regulatory mechanism of circRNA-mediated adipogenesis in chickens, providing new insights into the regulation of avian adipogenesis and a promising selective biomarker for the genetic improvement of excessive abdominal fat deposition in chickens.

Methods

Ethics statement

All animal experiments were conducted in accordance with the protocols approved by the Animal Welfare Committee of the State Key Laboratory for Agro-Biotechnology of the China Agricultural University (Permit Number: XK257). The birds were raised under the same environmental conditions, and food and water were provided ad libitum. For animal welfare, the birds were humanely slaughtered, and all efforts were made to minimize suffering.

Experimental animals and sample preparation

A population of 42-day-old female Arbor Acres broilers was humanely slaughtered to collect abdominal fat. According to abdominal fat percentage (AbFP, abdominal fat weight/eviscerated weight), eight broilers each with extremely high AbFP (HAbF, 1.83% ± 0.23%) and with extremely low AbFP (LAbF, 0.43% ± 0.24%), which showed an extremely significant statistical difference of AbFP between HAbF group and LAbF group [28], were selected to collect the abdominal adipose tissue (leaf fat), liver, heart, pancreas, kidney, pectoralis, and duodenum. These tissue samples were immediately snap-frozen in liquid nitrogen and stored at −80 ºC for further RNA extraction.

Cell culture and adipogenic differentiation

Immortalized chicken preadipocyte 2 (ICP2) cells were obtained from the Key Laboratory of Chicken Genetics and Breeding, Ministry of Agriculture (Northeast Agricultural University, Harbin, Heilongjiang, China). The ICP2 cells were maintained in a basal medium consisting of Dulbecco’s modified Eagle’s medium F12 (DMEM-F12) (Gibco, Gaithersburg, MD, USA) with a glucose concentration of 17.51 mmol/L supplemented with 10% fetal bovine serum (FBS) (Gibco) and 1% penicillin–streptomycin (Gibco). While growing to 80% confluence, ICP2 cells were incubated with differentiation medium comprising the basal medium supplemented with a final concentration of 160 μmol/L sodium oleate (Sigma, St. Louis, MO, USA) dissolved in sterile deionized water to induce adipogenic differentiation. The differentiation medium was changed every day. Human embryonic kidney 293 T cells and chicken embryonic fibroblast DF1 cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and were maintained in DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin–streptomycin (Gibco). All cells were cultured at 37 °C in a humidified 5% CO₂ atmosphere.

Complementary DNA (cDNA) synthesis and quantitative real-time PCR (qRT-PCR)

ICP2 cells were lysed using TRIzol reagent (TIANGEN, Beijing, China) for total RNA extraction. To detect circDOCK7 and mRNA expression, 2 μg of total RNA from each sample was reverse-transcribed into cDNA using the FastKing RT Kit (with gDNase) (TIANGEN) according to the manufacturer’s recommendations. A SYBR Green-based qRT-PCR was performed in a 20-μL reaction volume containing 10 μL 2× Universal SYBR Green Fast qPCR Mix (aBclonal, Wuhan, China), 8 μL RNase-free water, 0.5 μL each of forward and reverse primers (10 μmol/L), and 1 μL cDNA (approximately 300 ng). The qRT-PCR amplification protocol consisted of an initial denaturation at 95 °C for 15 min, 40 cycles of denaturation at 94 °C for 20 s as well as annealing and extension at 60 °C for 34 s. The housekeeping gene GAPDH served as an internal control to normalize the relative circRNA and mRNA expression.

To test miRNA expression, 2 μg of total RNA from each sample was reverse-transcribed into cDNA using the miRcute Plus miRNA First-Strand cDNA Kit (TIANGEN). A SYBR Green-based poly(A)-tailed qRT-PCR was performed in a 20-μL reaction volume containing 10 μL 2× miRcute Plus miRNA PreMix (SYBR&ROX) (TIANGEN), 8.2 μL RNase-free water, 0.4 μL each of forward and reverse primers (10 μmol/L), and 1 μL cDNA (approximately 300 ng). The miRNA qRT-PCR amplification protocol consisted of an initial denaturation at 95 °C for 15 min, 5 cycles of denaturation at 94 °C for 20 s, annealing at 64 °C for 30 s, and extension at 72 °C for 34 s, followed by 40 cycles of 94 °C for 20 s, 60 °C for 34 s. The housekeeping gene U6 served as an internal control to normalize relative miRNA expression. The qRT-PCR was performed on a Bio-Rad CFX96 Real-Time PCR system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The relative expression levels of circDOCK7, miRNAs and mRNAs were calculated using the 2^−∆∆CT method. The qRT-PCR primers for miRNA expression were designed using the miRprimer2 software [29] and those for circRNA and mRNA expression were designed using the National Center for Biotechnology Information (NCBI) Primer-BLAST [30]. All primers were synthesized by SinoGenoMax (Beijing, China) (Additional File 1: Table S1).

Cyclization validation of circDOCK7

Divergent and convergent primers were designed to amplify the backsplicing junction (BSJ) sites of circDOCK7 or linear DOCK7 mRNA, using cDNA and genomic DNA (gDNA) templates from chicken abdominal fat, respectively. The back-splicing sites of circDOCK7 were PCR-amplified by divergent primer PCR and validated by Sanger sequencing. To compare the half-lives of circDOCK7 and DOCK7, ICP2 cells were treated with a final dose of 2 μg/mL actinomycin D (Acmec, Shanghai, China) for 0, 4, 8, 12 and 24 h and then collected for further RNA extraction and expression analysis as mentioned above. To validate circDOCK7 resistance to RNase R digestion, 4 μg RNA from ICP2 cells was treated with RNase R in three replicates (20 U/μL, GENESEED, Guangzhou, Guangdong, China) according to the manufacturer’s instructions. For the control group, 4 μg of RNA was supplemented with RNase-free water and 10× RNase R buffer (RNase R−). For the RNase R digestion group, 4 μg RNA was mixed with 10 U RNase R, RNase-free water, and 10× RNase R buffer (RNase R+). Subsequently, the two groups were incubated for 30 min at 37 °C. The RNA samples were reverse-transcribed into cDNA using the FastKing RT Kit (with gDNase) (TIANGEN). The expression of circDOCK7 and DOCK7 in the two groups was detected by qRT-PCR. GAPDH was used as an internal control.

Isolation of nuclear and cytoplasmic fractions

The nuclear and cytoplasmic fractions and total RNA from ICP2 cells were isolated using a PairsTM kit (Part Number AM1921, Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. cDNA was synthesized as previously described. The U6 and GAPDH genes were used as marker genes for nuclear and cytoplasmic RNAs, respectively.

Fluorescence in situ hybridization (FISH)

A 5′-FAM-labeled probe 5′-TTCAT + TCCAGGAAGGGGAACC + TTACTGCCAATGATGGA-3′ specifically binding to circDOCK7 was designed and synthesized by GenePharma Co., Ltd. (Shanghai, China). ICP2 cells were seeded in confocal culture dishes and were fixed with 4% paraformaldehyde (Solarbio, Beijing, China). The fixed ICP2 cells were then hybridized with 2 μmol/L of fluorescence probes using a Fluorescent In Situ Hybridization Kit (Genepharma, Shanghai, China) according to the manufacturer’s instructions. The 4′,6-diamidino-2-phenylindole (DAPI) (Solarbio) was used to stain nuclei. Images were captured using a laser scanning confocal microscope (Nikon A1R, Tokyo, Japan).

Bioactive mitochondria were specifically labeled using MitoTracker Red CMXRos (Beyotime, Shanghai, China) in ICP2 cells, according to the manufacturer’s instructions. Briefly, the cells were cultured in a confocal dish. After removing the basal medium, a final concentration of 100 nmol/L MitoTracker Red CMXRos diluted with Hank’s Balanced Salt Solution (HBSS, with Ca²⁺ and Mg²⁺) (Beyotime) was added and incubated at 37 ºC for 30 min. Thereafter, the MitoTracker Red CMXRos was replaced with pre-heated fresh basal medium at 37 ºC. The endoplasmic reticulum was specifically labeled with ER-Tracker Red (Beyotime) in ICP2 cells, according to the manufacturer’s instructions. Briefly, cells were cultured in a confocal dish and washed with HBSS (Beyotime). Subsequently, the cells were incubated with pre-heated 1:1,000 ER-Tracker Red staining solution of ER-Tracker Red and ER-Tracker Red diluent at 37 °C for 30 min. ICP2 cells were observed microscopically using a laser scanning confocal microscope (Nikon A1R).

Cell Counting Kit-8 (CCK-8) assay

ICP2 cells were seeded in 96-well plates and cultured in basal medium. At 6, 24, 48, 72 and 96 h post-transfection, cell proliferation was monitored using the Cell Counting Kit-8 (Beyotime), according to the manufacturer’s protocol. After 1 h of incubation, absorbance at 450 nm was measured using a SpectraMax® i3x Multi-Mode Microplate Reader (Molecular Devices Corporation, Sunnyvale, CA, USA).

5-Ethynyl‐2′‐deoxyuridine (EdU) assay

ICP2 cells were seeded in 12-well plates and cultured in basal medium. At 48 h post-transfection, the cells were stained with Alexa Fluor 555 for 2 h using a BeyoClick™ EdU Cell Proliferation Kit (Beyotime), according to the manufacturer’s protocol. Cell nuclei were stained blue and EdU-positive cells were stained red. Cells were microscopically observed and photographed using an Echo Revolve fluorescence microscope (Echo Laboratories, San Diego, CA, USA). The EdU-positive and total cells in the photofluorogram were counted using the ImageJ software [31].

Cell cycle assay

ICP2 cells were seeded in 6-well plates and cultured in basal medium. At 48 h post-transfection, cells were harvested by centrifugation at 1,000 × g for 5 min. After washing with cold phosphate buffered saline (PBS) (Gibco), the cells were fixed in cold 70% ethanol at 4 ℃ overnight. Subsequently, the cells were re-collected by centrifugation at 1,000 × g for 5 min and incubated with propidium staining solution (Beyotime) at 37 ºC for 30 min in the dark conditions, according to manufacturer’s instructions. The cell cycle was analyzed by flow cytometry using a BD FACSCalibur flow cytometer (BD Biosciences, San Diego, CA, USA), and the data were analyzed using the FlowJo_v10.8.1 software.

Measurement of intracellular acetyl coenzyme A (acetyl-CoA) and triglycerides (TG)

To investigate the effects of genes on intracellular acetyl-CoA and triglycerides, ICP2 cells were treated with a final concentration of 160 μmol/L sodium oleate (Sigma) for 48 h after transfection. ICP2 cells were then washed twice with PBS and lysed with the lysis buffer. After ultrasonication, the cell mixture was resuspended by centrifugation at 8,000 × g for 10 min at 4 ºC. The intracellular acetyl-CoA content was determined using an Acetyl Coenzyme A Content Assay Kit (Boxbio, Beijing, China), according to the manufacturer’s instructions. The ICP2 cells were then washed twice with PBS, and lysis buffer was added for ultrasonication. Thereafter, the cell suspension was incubated for 10 min at 70 °C and centrifuged at 2,000 × g for 5 min at 25 °C. The intracellular triglyceride content was detected using a Tissue Triglyceride (TG) Content Assay Kit (Applygen, Beijing, China), according to the manufacturer’s instructions. The intracellular total protein content was assessed using a BCA Protein Quantification Kit (Applygen) to normalize the acetyl-CoA and triglyceride content.

Glucose uptake capacity assay

ICP2 cells were seeded into 6-well plates and transfected with the pcDNA3.1-EGFP and pcDNA3.1-ACSL1-EGFP plasmids. At 48 h post-transfection, the glucose uptake capacity of the cells was monitored using the Glucose Uptake Assay Kit (Dojindo, Tokyo, Japan), according to the manufacturer’s instructions. Briefly, the cells were washed twice and incubated with pre-heated glucose-free medium (Solarbio) for 15 min at 37 °C. Thereafter, the cells were incubated with the pre-heated probe solution for 15 min at 37 ºC and washed twice with pre-cooled WI Solution (1×). Pre-cooled WI Solution (1×) was added again and incubated at 25 °C for 5 min. Cells were microscopically observed and photographed using an Echo Revolve fluorescence microscope (Echo Laboratories). The total number of cells was determined using the Cell Count Normalization Kit (Dojindo), according to the manufacturer’s instructions. The fluorescence intensity of the cell nucleus (excitation filter: 350 nm; emission filter: 461 nm) and glucose uptake (excitation filter: 545 nm; emission filter: 605 nm) were measured using a SpectraMax® i3x Multi-Mode Microplate Reader (Molecular Devices Corporation).

Oil Red O staining

ICP2 cells were washed thrice with PBS (Gibco) and fixed in 4% paraformaldehyde solution (Solarbio) for 30 min. After washing thrice again with PBS, the cells were stained with Oil Red O (Sigma) dissolved in 100% isopropyl alcohol for 15 min at 25 ºC. Following infiltration with 60% isopropyl alcohol for 10 s, the cells were washed thrice with PBS and imaged under a microscope (Leica, Bensheim, Germany). Intracellular Oil Red O was dissolved in 100% isopropyl alcohol for 5 min, and the content of lipid droplets was quantified spectrophotometrically by measuring the absorbance at 490 nm.

Nile red fluorescent staining

ICP2 cells were washed thrice with PBS, fixed in 4% formaldehyde (Solarbio) for 10 min, and then incubated with Nile red fluorescent dye (Applygen) for 10 min at 25 ºC. After washing with PBS, the cells were incubated with DAPI for 10 min to stain the nuclei at 25 ºC. Cells were microscopically observed and photographed using an Echo Revolve fluorescence microscope (Echo Laboratories).

Bioinformatics analysis

The secondary structure of circDOCK7 was predicted using the RNAfold web server [32]. Open reading fragments (ORFs) with a minimum length of 150 nt were extracted using the EMBOSS GetOrf software [33]. The internal ribosome entry site (IRES) elements of circDOCK7 were predicted using IRESfinder, a specialized tool for IRES prediction in eukaryotic cells [34]. The N6-methyladenosine (m⁶A) modification sites in the circDOCK7 sequence were predicted using SRAMP (sequence-based RNA adenosine methylation site predictor) [35]. The RNA-RNA duplex and minimum free energy (MFE) between circDOCK7 and gga-miR-301b-3p as well as between gga-miR-301b-3p and the 3′ UTR of the ACSL1 gene were analyzed using RNAhybrid [36]. Subcellular localization of chicken ACSL1 protein were predicted using UniProt [37].

Construction of the ceRNA regulatory network

Differentially expressed miRNAs that potentially interact with circDOCK7 and their differentially expressed target mRNAs that are closely involved in lipid metabolism were predicted using an intersection of miRanda [38] and TargetScan [39]. The circDOCK7-miRNA pairs with a negative expression correlation, miRNA-mRNA pairs with a negative expression correlation, and circDOCK7-mRNA pairs with a positive expression correlation were selected to establish the circDOCK7-associated ceRNA network, which was visualized using the Cytoscape software, version 3.8.2 [40].

Plasmid construction and RNA oligonucleotide synthesis

To construct dual-luciferase reporter plasmids, the ACSL1 3′ UTR region containing the complementary binding sites of the gga-miR-301b-3p seed region with an insert containing XhoI and NotI restriction enzyme sites was cloned into the XhoI and NotI (Takara, Tokyo, Japan) double-digested psi-CHECK™-2 vector (Promega, Madison, WI, USA) using the Trelief™ SoSoo Cloning Kit (TSINGKE, Beijing, China) for wild-type plasmid construction, and named ACSL1-3′UTR-WT, according to the manufacturer's specifications. The complementary binding site of gga-miR-301b-3p to the ACSL1 3′-UTR was deleted and cloned to construct the mutant-type plasmid ACSL1-3′-UTR-Mut. Similarly, the wild-type circDOCK7 plasmid containing a complementary gga-miR-301b-3p binding site (circDOCK7-WT) and the mutant-type circDOCK7 plasmid of lacking the complementary gga-miR-301b-3p binding site (circDOCK7-Mut) were constructed. All primers were synthesized by SinoGenoMax (Beijing, China) (Additional File 1: Table S1).

To construct the circDOCK7 overexpression vector, the full-length circDOCK7 with EcoRI and BamHI restriction enzyme sites was cloned into the EcoRI and BamHI (Takara) double-digested pLC5-ciR vector (GENESEED, Guangzhou, China) using the Trelief™ SoSoo Cloning Kit (TSINGKE), and named oe-circDOCK7. To construct the ACSL1 overexpression vector, the complete coding sequences of the ACSL1 gene with a deleted termination codon and inserted NheI and EcoRI restriction enzyme sites were cloned into the NheI and EcoRI (Takara) double-digested pcDNA3.1-EGFP vector (Invitrogen), using the Trelief™ SoSoo Cloning Kit (TSINGKE), and named pcDNA3.1-ACSL1-EGFP. Plasmid DNA was purified using the EndoFree Maxi Plasmid Kit (TIANGEN), according to the manufacturer’s instructions.

Small interfering RNA (siRNA) oligonucleotides siACSL1 (sense: CCUCACGACCUACUGGUAUTT; antisense: AUACCAGUAGGUCGUGAGGTT) designed to specifically knockdown the ACSL1 gene, the siRNA oligonucleotides sicircDOCK7 (sense: CAUUGGCAGUAAGGUUCCCTT; antisense: GGGAACCUUACUGCCAAUGTT) designed to specifically knockdown circDOCK7, miR-301b-3p agomir specifically for gga-miR-301b-3p overexpression, miR-301b-3p antagomir specifically for gga-miR-301b-3p knockdown, and their corresponding negative controls (NCs), were synthesized by GenePharma Co., Ltd. (Shanghai, China). All cell transfection experiments were performed using Lipofectamine 3000 Transfection Reagent (Invitrogen), according to the manufacturer’s instructions.

Dual-luciferase reporter assay

After seeding 293 T cells and DF1 cells in 24-well plates, they were co-transfected in triplicate with miR-301b-3p agomir or agomir NC (80 nmol/L) and the above-mentioned wild-type or mutant plasmids (500 ng per well). At 48 h post-transfection, the cells were washed three times with PBS and lysed with 1× passive lysis buffer (Promega) for 15 min. Firefly and Renilla luminescence were measured using the Dual-Luciferase® Reporter Assay System (Promega) on a SpectraMax® i3x Multi-Mode Microplate Reader (Molecular Devices Corporation). Renilla luciferase activity was normalized to the firefly luciferase activity.

RNA Pull-down assay

A biotinylated probe specifically binding to circDOCK7 was designed, and an oligo probe served as a negative control (NC). Approximately, 1 × 10⁷ ICP2 cells were harvested, lysed, and ultrasonicated. The biotinylated circDOCK7 probe (TSINGKE) and NC probe were denatured by incubating at 90 °C for 2 min and then in an ice bath for 2 min. After adding 50 μL of RNA structure buffer and 20 μL of RNase-free water, the probes were kept at 25 °C for 20 min to form the RNA secondary structure. Subsequently, the probes were incubated with streptavidin magnetic beads (Life Technologies, Grand Island, NY, USA) at 25 ºC for 30 min to generate probe-coated beads. The cell lysates were incubated with probe-coated beads at 4 °C overnight. The miRNAs that were sponged by circDOCK7 in the pull-down materials were reverse-transcribed into cDNA, and gga-miR-301b-3p expression was analyzed by a qRT-PCR assay, as mentioned above.

Statistical analysis

All data are presented as mean ± standard deviation. The relative gene expression levels are calculated using 2^−∆∆Ct method and shown as fold changes compared with that in the control group. The normality of experimental data was performed using Shapiro–Wilk test before the significant difference by statistics analysis. Statistically significant differences between the two experimental groups were determined via the t-test using the SPSS software (version 23.0; IBM, Chicago, IL, USA). Significance was set at P < 0.05, and extreme significance was set at P < 0.01. The results were analyzed using GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA).

Results

Characterization and expression profile of circDOCK7

circDOCK7 is a 654-nucleotide-long circRNA derived from the head-to-tail splicing of exons 19–22 of the DOCK7 gene located on chromosome 8 (Fig. 1A, Additional File 1: Table S2). To exclude the possibility that such head-to-tail splicing products arise from genomic rearrangements and trans-splicing, we first designed divergent primers that specifically amplify only the circular transcript (circDOCK7) and convergent primers that specifically amplify the linear parental transcript (DOCK7) using cDNA and gDNA templates, respectively (Fig. 1A). The circDOCK7 was observed only in divergent primer-amplified PCR products from cDNA, but not from the gDNA of ICP2 cells, and the backsplicing junction sites were validated by Sanger sequencing (Fig. 1B and C). Moreover, endogenous circDOCK7 abundance was not significantly changed upon exposure to RNase R, in which the significantly decreased expression levels of the linear DOCK7 and GAPDH genes supported the desirable efficacy of the RNase R treatment, indicating that circDOCK7 was resistant to RNase R digestion (Fig. 1D). The RNA stability of circDOCK7 and its linear parental gene DOCK7, as determined using actinomycin D, a small molecule inhibitor of transcription, showed that circDOCK7 was highly stable with its half-life exceeding 24 h, while the expression of the DOCK7 gene was remarkably reduced in a time-dependent manner and exhibited more than 65% reduction at 24 h (Fig. 1E). These results suggest that circDOCK7 was stable with RNase R resistance and a longer half-life. The secondary structure prediction of circDOCK7, based on the minimum free energy (MFE), showed that circDOCK7 has a stem-loop structure (Additional file 2: Fig. S1). To determine the subcellular localization of circDOCK7, we conducted a qRT-PCR analysis of nuclear and cytoplasmic circDOCK7 expression and FISH with a 5'FAM-labeled circRNA probe that precisely recognizes the backsplicing junction sites of circDOCK7 backsplicing region to determine its subcellular location. We found that circDOCK7 was primarily located in the cytoplasm of ICP2 cells (Fig. 1F and G). These results indicated that circDOCK7 is an exon-based RNase-resistant circRNA that predominantly localizes to the cytoplasm.

The expression profiles determined by qRT-PCR showed that circDOCK7 had the highest expression in abdominal fat among the seven detected tissues, and a significantly higher expression in abdominal fat tissues in the high abdominal fat (HAbF) group than in the low abdominal fat (LAbF) group (Fig. 1H). During the proliferation and adipogenic differentiation of chicken abdominal preadipocytes, the expression of circDOCK7 gradually increased in a time-dependent manner (Fig. 1I and J). These findings indicate that circDOCK7 may play a positive regulatory role in adipogenesis.

CircDOCK7 knockdown inhibits the proliferation of chicken abdominal preadipocytes

To explore the effects of circDOCK7 on abdominal adipogenesis in chickens, we first monitored the cell proliferation capacity of chicken abdominal preadipocytes via gain- and loss-of-function experiments by transfecting the circDOCK7 overexpression vector pLC5-circDOCK7 and siRNA sicircDOCK7, respectively. The CCK8 assay showed no significant difference in the number of living chicken abdominal preadipocytes in the experimental group compared to the control group at 6, 24, 48, 72 and 96 h post-transfection (Additional file 2: Fig. S2A). The remarkable overexpression of circDOCK7 (by approximately 2,700-fold) in pLC5-circDOCK7-treated ICP2 cells for 48 h was confirmed by qRT-PCR (Additional file 2: Fig. S2B). The EdU staining showed no significant change in the proportion of EdU-positive chicken abdominal preadipocytes in the circDOCK7 overexpression group compared to the control group (Additional file 2: Fig. S2C and D). A flow-cytometric cell cycle analysis revealed that circDOCK7 overexpression did not significantly change the G0/G1-, S-, and G2/M-phase populations of chicken abdominal preadipocytes (Additional file 2: Fig. S2E and F). CircDOCK7 knockdown significantly decreased the number of living chicken abdominal preadipocytes, as determined by the CCK8 assay (Fig. 2A). A qRT-PCR analysis showed that circDOCK7 expression caused an approximately 84% reduction in sicircDOCK7-treated ICP2 cells for 48 h (Fig. 2B). The EdU staining assay revealed significantly reduced EdU-positive chicken abdominal preadipocytes in the circDOCK7 knockdown group compared to the siNC group (Fig. 2C and D). Moreover, circDOCK7 knockdown prevented cell cycle progression, resulting in more cell populations arrested in the G0/G1 phase and, thus, fewer cell populations in the S phase of chicken abdominal preadipocytes (Fig. 2E and F), indicating that circDOCK7 knockdown inhibited the proliferation of chicken abdominal preadipocytes.

Fig. 2 — Effects of circDOCK7 knockdown on the proliferation of chicken abdominal preadipocytes. A CCK8 assay of chicken abdominal preadipocytes transfected with siNC and sicircDOCK7 at 6, 24, 48, 72 and 96 h post-transfection. B Detection of circDOCK7 knockdown in chicken abdominal preadipocytes 48 h post-transfection with sicircDOCK7. The relative gene expression levels are shown as fold changes compared with that in the siNC group. The same below. C Proliferation of chicken abdominal preadipocytes determined by 5-ethynyl-2′-deoxyuridine (EdU) after 48 h of transfection with sicircDOCK7. D Histogram showing the proportion of EdU-positive cells using ImageJ. E and F Cell cycle analysis of chicken abdominal preadipocytes after 48 h transfection with sicircDOCK7 using flow cytometry. ^*P < 0.05, ^**P < 0.01

CircDOCK7 promotes the adipogenic differentiation of chicken abdominal preadipocytes

To further investigate the regulatory role of circDOCK7 in abdominal adipogenesis in chickens, we detected intracellular lipid droplet accumulation and intracellular triglyceride and acetyl-CoA contents via gain- and loss-of-function assays in differentiated ICP2 cells. Compared with the pLC5-ciR control group, a remarkable increase in circDOCK7 expression (by approximately 360-fold) was detected in circDOCK7-overexpressing ICP2 cells by a qRT-PCR analysis (Fig. 3A). This resulted in a significant increase in intracellular lipid droplet accumulation upon circDOCK7 overexpression, as determined by Oil Red O and lipophilic fluorophore Nile red staining (Fig. 3B–D). Moreover, excessive circDOCK7 expression led to a significant increase in the content of intracellular triglycerides and acetyl-CoA, the main precursor of lipid synthesis (Fig. 3E and F). The mRNA expression of marker genes closely responsible for adipogenesis, including peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-binding protein α (CEBPα), was significantly increased upon circDOCK7 stimulation (Fig. 3G). Conversely, intracellular lipid droplet accumulation as well as acetyl-CoA and triglyceride levels were remarkably decreased by circDOCK7 interference, accompanied by significantly inhibited mRNA abundance of the CEBPα gene (Fig. 3H–N). These results indicate that circDOCK7 facilitates the adipogenic differentiation of chicken abdominal preadipocytes.

Fig. 3 — Effects of circDOCK7 on the adipogenic differentiation of chicken abdominal preadipocytes. A Detection of circDOCK7 overexpression after 48 h of transfection with circDOCK7 overexpression vector in differentiated chicken abdominal adipocytes. The relative gene expression levels are shown as fold changes compared with that in the pLC5-ciR group. The same below. B and C Representative images of Oil Red O staining and lipid droplet content of circDOCK7-overexpressing differentiated chicken abdominal adipocytes. D Representative images of Nile red fluorescent staining of circDOCK7-overexpressing differentiated chicken abdominal adipocytes. E and F Intracellular triglyceride and acetyl-CoA levels of circDOCK7-overexpressing differentiated chicken abdominal adipocytes. G Relative mRNA expression levels of *PPARγ* and *CEBPα* in circDOCK7-overexpressing differentiated chicken abdominal adipocytes. H Detection of circDOCK7 knockdown after 48 h of transfection with sicircDOCK7 in differentiated chicken abdominal adipocytes. I and J Representative images of Oil Red O staining and lipid droplet content of circDOCK7-knockdown differentiated chicken abdominal adipocytes. K Representative images of Nile red fluorescent staining of circDOCK7-knockdown differentiated chicken abdominal adipocytes. L and M Intracellular triglyceride and acetyl-CoA levels of circDOCK7-knockdown differentiated chicken abdominal adipocytes. N Relative mRNA expression levels of *PPARγ* and *CEBPα* in circDOCK7-knockdown differentiated chicken abdominal adipocytes. ^*P < 0.05, ^**P < 0.01

CircDOCK7 acts as a sponge for gga-miR-301b-3p to play biological roles

circRNAs are implicated in various biological processes through diverse regulatory mechanisms, such as sponging miRNA, modulating their host gene transcription, and encoding proteins or peptides. To elucidate the functional mechanism of circDOCK7 underlying adipogenesis in chickens, we first evaluated the translation potential of circDOCK7 based on the fact that endogenous circRNAs with ORFs can be translated into proteins or peptides driven by an IRES and m⁶A modification. A bioinformatics analysis revealed that circDOCK7 has an IRES (Score 0.7133933991446173) and two m⁶A modification sites in 195A (high confidence) and 369A (moderate confidence) (Additional file 2: Fig. S3), but no ORFs, suggesting that it has almost no protein-coding potential. Second, we assessed the co-expression tendency of circDOCK7 and DOCK7 during adipogenic differentiation of chicken abdominal preadipocytes and found that circDOCK7 had no significant correlation with its parental genes (Pearson correlation coefficient = −0.3024, P = 0.2734) (Additional file 2: Fig. S4A and B). To further confirm whether circDOCK7 modulated the transcriptional expression of its host DOCK7 gene, we measured the mRNA expression levels of DOCK7, while circDOCK7 was overexpressed and knocked down in proliferated and differentiated chicken abdominal preadipocytes, respectively. A qRT-PCR analysis showed no significant change in the mRNA expression level of DOCK7 gene in the proliferative and differentiated chicken abdominal preadipocytes upon circDOCK7 overexpression (Additional file 2: Fig. S4C) or interference (Additional file 2: Fig. S4D). This indicates that circDOCK7 could not regulate parental gene expression during adipogenesis in chickens.

Based on the expression profiles of circDOCK7, potential miRNAs absorbed by circDOCK7 and their potential target mRNAs, the constructed ceRNA regulatory network showed that circDOCK7 might interact with five miRNAs: gga-miR-1354, gga-miR-143-3p, gga-miR-301b-3p, novel_miR_105, and novel_miR_273, wherein gga-miR-301b-3p might target the ACSL1 gene, an indispensable regulator at the critical juncture of de novo lipid synthesis that is involved in several lipid-related signaling pathways, including fatty acid metabolism, fatty acid biosynthesis, fatty acid degradation, PPAR signaling pathway, and adipocytokine signaling pathway (Additional file 2: Fig. S5A). Furthermore, circDOCK7 expression was significantly positively correlated (Pearson correlation coefficient = 0.8007, P = 0.0003) with ACSL1 expression (Additional file 2: Fig. S5B and C). The MFEs of the RNA duplexes formed by circDOCK7 and gga-miR-301b-3p as well as gga-miR-301b-3p and ACSL1 gene were −22.9 and −22.7 kcal/mol, respectively, indicating the high strength of these hybridizations (Additional file 2: Fig. S5D and E). Additionally, in proliferative chicken abdominal preadipocytes, the expression level of gga-miR-301b-3p was remarkably increased by circDOCK7 interference, although there was no significant change with circDOCK7 overexpression (Fig. 4A). In differentiated chicken abdominal preadipocytes induced by sodium oleate, the overexpression of circDOCK7 significantly inhibited gga-miR-301b-3p expression compared to the pLC5-ciR control group, whereas the knockdown of circDOCK7 significantly enhanced gga-miR-301b-3p expression compared to the siNC control group (Fig. 4B). In contrast, the ACSL1 mRNA abundance was significantly decreased in both sicircDOCK7-treated proliferative and differentiated ICP2 cells compared to the siNC group, and was significantly increased in differentiated ICP2 cells transfected with circDOCK7 overexpression vector compared to the control group (Fig. 4C and D). This inspired us to explore the circDOCK7-mediated ceRNA regulation during chicken adipogenesis.

Fig. 4 — circDOCK7 functions as a gga-miR-301b-3p sponge. A and B Relative expression of gga-miR-301b-3p in proliferative and differentiated chicken abdominal preadipocytes upon circDOCK7 overexpression and knockdown. C and D Relative expression of the *ACSL1* gene in proliferative and differentiated chicken abdominal preadipocytes upon circDOCK7 overexpression and knockdown. E Construction of dual-luciferase reporter vectors for the validation of gga-miR-301b-3p binding to circDOCK7. WT: wild-type vector; Mut: mutant vector; *hRluc*: *Renilla* luciferase; *hluc* + : firefly luciferase. F Validation of the interaction between gga-miR-301b-3p and circDOCK7 via a dual-luciferase reporter assay in 293 T cells and DF1 cells. G Detection of the combination of circDOCK7 and gga-miR-301b-3p by an RNA pull-down assay. H qRT-PCR analysis of gga-miR-301b-3p expression pulled down by the circDOCK7 probe. ^*P < 0.05, ^**P < 0.01

To confirm the interaction between circDOCK7 and gga-miR-301b-3p, we first predicted one gga-miR-301b-3p-binding site in the circDOCK7 sequences and constructed wild-type and mutant plasmids that contained and lacked this binding site, respectively (Fig. 4E). As expected, a dual-luciferase reporter assay revealed that co-transfection of miR-301b-3p agomir and wild-type circDOCK7 significantly reduced the relative luciferase activity in both 293 T and DF1 cells; however, the co-transfection of miR-301b-3p agomir and mutant circDOCK7 did not affect the relative luciferase activity (Fig. 4F). This demonstrated direct binding between circDOCK7 and gga-miR-301b-3p based on their complementary sequences. To further determine the direct interaction of circDOCK7 and gga-miR-301b-3p in chicken abdominal preadipocytes, we conducted a pull-down experiment in chicken abdominal preadipocytes and confirmed the enrichment of gga-miR-301b-3p in the circDOCK7 probe-treated group, but not in the Bio-NC group (Fig. 4G). Moreover, gga-miR-301b-3p expression was remarkably increased in the circDOCK7 probe-treated group compared to the Bio-NC group, as determined by qRT-PCR (Fig. 4H). These results suggested that circDOCK7 directly binds to gga-miR-301b-3p in chicken abdominal preadipocytes.

gga-miR-301b-3p inhibits the proliferation of chicken abdominal preadipocytes

To determine whether gga-miR-301b-3p functions in chicken adipogenesis, we first monitored the tissue expression profiles of HAbF and LAbF broilers. A qRT-PCR assay showed that gga-miR-301b-3p expression was the most abundant in abdominal fat among the seven detected tissues and was significantly downregulated in the abdominal fat of HAbF broilers than that of LAbF broilers (Fig. 5A). We then detected gga-miR-301b-3p expression in chicken abdominal preadipocytes at different stages of proliferation and conducted gain- and loss-of-function experiments by transfecting miR-301b-3p agomir and miR-301b-3p antagomir into ICP2 cells, respectively. The results showed that gga-miR-301b-3p expression was gradually downregulated during chicken abdominal preadipocyte proliferation in a time-dependent manner (Fig. 5B). A CCK8 assay showed that gga-miR-301b-3p overexpression significantly decreased the number of living ICP2 cells at 24, 48, 72, and 96 h post-transfection, whereas gga-miR-301b-3p knockdown significantly increased the number of living ICP2 cells (Fig. 5C and D). Similarly, EdU staining revealed that remarkably fewer EdU-positive cells were accompanied by gga-miR-301b-3p overexpression (Fig. 5E and F), contrary to those triggered by gga-miR-301b-3p interference (Fig. 5G and H). Additionally, a cell cycle analysis showed that the proportion of ICP2 cells was significantly increased in the G0/G1 phase and significantly decreased in the S phase upon gga-miR-301b-3p overexpression (Fig. 5I and J); gga-miR-301b-3p interference exhibited the opposite effects (Fig. 5K and L). These results indicated that gga-miR-301b-3p inhibited the proliferation of chicken abdominal preadipocytes by blocking their progression from the G0/G1 phase to the S phase.

Fig. 5 — Effects of gga-miR-301b-3p on the proliferation of chicken abdominal preadipocytes. A Tissue expression pattern of gga-miR-301b-3p in chickens with high and low abdominal fat percentage. B Expression pattern of gga-miR-301b-3p during the proliferation of chicken abdominal preadipocytes. C CCK8 assay of chicken abdominal preadipocytes transfected with miR-301b-3p agomir and miR-301b-3p agomir NC. D CCK8 assay of chicken abdominal preadipocytes transfected with miR-301b-3p antagomir and miR-301b-3p antagomir NC. E Proliferation of chicken abdominal preadipocytes determined by EdU after 48 h of transfection with miR-301b-3p agomir and miR-301b-3p agomir NC. F Histogram showing the proportion of gga-miR-301b-3p-overexpressing EdU-positive cells using ImageJ. G Proliferation of chicken abdominal preadipocytes determined by EdU after 48 h of transfection with miR-301b-3p antagomir and miR-301b-3p antagomir NC. H Histogram showing the proportion of gga-miR-301b-3p-knockdown EdU-positive cells using ImageJ. I and J Flow-cytometric cell cycle analysis of chicken abdominal preadipocytes after 48 h of transfection with miR-301b-3p agomir and miR-301b-3p agomir NC. K and L Flow-cytometric cell cycle analysis of chicken abdominal preadipocytes after 48 h of transfection with miR-301b-3p antagomir and miR-301b-3p antagomir NC. ^*P < 0.05, ^**P < 0.01

gga-miR-301b-3p suppresses the adipogenic differentiation of chicken abdominal preadipocytes

To further assess the functions of gga-miR-301b-3p in chicken adipogenesis, we monitored its expression pattern during the adipogenic differentiation of chicken abdominal preadipocytes and the changes in intracellular acetyl-CoA, triglyceride, and lipid droplet accumulation in differentiated ICP2 cells with gga-miR-301b-3p overexpression and knockdown, respectively. Here, gga-miR-301b-3p was significantly downregulated in differentiated than in undifferentiated chicken abdominal preadipocytes (Fig. 6A). A significant decrease in intracellular lipid droplet content was detected in ICP2 cells transfected with gga-miR-301b-3p agomir for 48 h, as determined by Oil Red O and Nile red fluorescent staining assays (Fig. 6B–D). Additionally, intracellular triglyceride and acetyl-CoA levels were significantly lower in the gga-miR-301b-3p overexpression group than in the control group (Fig. 6E, F). In contrast, intracellular lipid droplet, triglyceride, and acetyl-CoA levels were significantly increased in the gga-miR-301b-3p knockdown group than in the control group (Fig. 6G–K). These results indicate that gga-miR-301b-3p suppresses the adipogenic differentiation of abdominal preadipocytes in chickens.

Fig. 6 — Effects of gga-miR-301b-3p on the adipogenic differentiation of chicken abdominal preadipocytes. A Expression pattern of gga-miR-301b-3p during the adipogenic differentiation of chicken abdominal preadipocytes. B, C Representative images of Oil Red O staining and Nile red fluorescent staining of gga-miR-301b-3p-overexpressing differentiated chicken abdominal adipocytes. D Detection of lipid droplet content of gga-miR-301b-3p-overexpressing differentiated chicken abdominal adipocytes. E and F Intracellular triglyceride and acetyl-CoA levels of gga-miR-301b-3p-overexpressing differentiated chicken abdominal adipocytes. G and H Representative images of Oil Red O staining and Nile red fluorescent staining of gga-miR-301b-3p-knockdown differentiated chicken abdominal adipocytes. I Detection of the lipid droplet content of gga-miR-301b-3p-knockdown differentiated chicken abdominal adipocytes. J and K Intracellular triglyceride and acetyl-CoA levels of gga-miR-301b-3p-knockdown differentiated chicken abdominal adipocytes. ^*P < 0.05, ^**P < 0.01

ACSL1 is a direct target of gga-miR-301b-3p

The miRNA gga-miR-301b-3p was derived from intron 1 of the spindle and kinetochore-associated complex subunit 2 pseudogene 1 (SKA2) gene in the chicken genome (Fig. 7A). Our results suggested that the seed region gga-miR-301b-3p could bind to the 3′ untranslated region (UTR) of the ACSL1 gene, which is conserved among species, including human, chimp, mouse, rat, pig, cow, lizard and western clawed from (Xenopus tropicalis) (Fig. 7B). To confirm the interaction between gga-miR-301b-3p and ACSL1, we constructed wild-type and mutant dual-luciferase reporter plasmids that contained and lacked the binding sites of the gga-miR-301b-3p seed region in the ACSL1 gene 3′-UTR, named ACSL1-3′UTR-WT and ACSL1-3′UTR-Mut, respectively (Fig. 7C). The dual-luciferase reporter plasmids were co-transfected with miR-301b-3p agomir or agomir NC into 293 T and DF1 cells. As expected, a dual-luciferase reporter assay revealed that gga-miR-301b-3p significantly decreased the relative luciferase activity of ACSL1-3′UTR-WT but did not affect that of ACSL1-3′UTR-Mut in either 293 T cells or DF1 cells (Fig. 7D). Moreover, the ACSL1 mRNA levels were significantly suppressed upon miR-301b-3p overexpression and significantly enhanced upon miR-301b-3p knockdown in both proliferative and differentiated chicken abdominal preadipocytes (Fig. 7E and F). These results indicated that gga-miR-301b-3p directly targeted the ACSL1 gene and inhibited its post-transcriptional expression.

Fig. 7 — Validation of the *ACSL1* gene as a direct target of gga-miR-301b-3p. A Schematic diagram of the genomic location of gga-miR-301b-3p. The sequences encoding the precursor gga-miR-301b-3p are shown, with the mature gga-miR-301b-3p sequences highlighted in red. B Complementary sequences of gga-miR-301b-3p and the 3′ UTR of the *ACSL1* gene of different species. The seed region of gga-miR-301b-3p is highlighted in red; potential gga-miR-301b-3p-binding sites in the 3′ UTR of the *ACSL1* gene are shown in blue. C Construction of dual-luciferase reporter vectors for the validation of gga-miR-301b-3p targeting the *ACSL1* gene. WT: wild-type vector; mut: mutant vector; *hRluc*: *Renilla* luciferase; *hluc* + : firefly luciferase. D Validation of the interaction between gga-miR-301b-3p and the 3′ UTR of the *ACSL1* gene by a dual-luciferase reporter assay in 293 T cells and DF1 cells. E Relative *ACSL1* mRNA expression in gga-miR-301b-3p-overexpressing and -knockdown proliferative chicken abdominal preadipocytes. The relative gene expression levels are shown as fold changes compared with that in the agomir NC and antagomir NC groups, respectively. The same below. F Relative *ACSL1* mRNA expression in gga-miR-301b-3p-overexpressing and -knockdown differentiated chicken abdominal preadipocytes. ^*P < 0.05, ^**P < 0.01

Subcellular localization and expression profiles of chicken ACSL1 protein

Most proteins can exert their functions in multiple compartments, which is determined by their subcellular localization. To determine the subcellular localization of the chicken ACSL1 protein, we first predicted it using UniProt and found that chicken ACSL1 was likely located in the endoplasmic reticulum, mitochondria, and membranes (Additional file 2: Fig. S6). Subsequently, our fluorescence staining assays showed that the chicken ACSL1 protein was indeed distributed in the endoplasmic reticulum and mitochondria of chicken abdominal preadipocytes (Fig. 8A). The tissue expression profiles of the ACSL1 gene in HAbF and LAbF broilers showed that ACSL1 exhibited the highest mRNA expression in abdominal fat and was significantly upregulated in the abdominal fat tissues of the HAbF group compared to the LAbF group (Fig. 8B). Moreover, ACSL1 showed a gradual increase in mRNA expression during the proliferation and adipogenic differentiation of chicken abdominal preadipocytes (Fig. 8C and D). These results suggest that ACSL1 plays a crucial role in abdominal adipogenesis in chickens.

Fig. 8 — Subcellular localization and expression profiles of chicken ACSL1 protein. A Subcellular localization of ACSL1 in chicken abdominal preadipocytes. MT represents mitochondrion. ER represents endoplasmic reticulum. Cell nuclei were stained with DAPI. B Tissue expression pattern of the *ACSL1* gene in chickens with high and low abdominal fat percentage. C and D Expression pattern of *ACSL1* during the proliferation and adipogenic differentiation of chicken abdominal preadipocytes. ^*P < 0.05, ^**P < 0.01

ACSL1 gene facilitates proliferation and glucose uptake in chicken abdominal preadipocytes

To explore the effects of the ACSL1 gene on the proliferation of chicken abdominal preadipocytes, we performed gain- and loss-of-function experiments by transfecting the overexpression vector and siRNA into ICP2 cells. The number of living cells was significantly increased upon ACSL1 overexpression but was significantly decreased upon ACSL1 silencing, as determined by the CCK8 assay (Fig. 9A and B). Accordingly, EdU staining showed that the proportion of EdU-positive chicken abdominal preadipocytes was markedly increased by ACSL1 overexpression and markedly decreased by ACSL1 silencing (Fig. 9C and D). Moreover, cell cycle analysis demonstrated that ACSL1 overexpression promoted normal cell cycle progression characterized by significantly decreased G0/G1-phase and significantly increased S- and G2/M-phase cell populations (Fig. 9E). In contrast, ACSL1 silencing produced the opposite effect and inhibited the normal cell cycle progression (Fig. 9F). However, the intracellular glucose uptake capacity of chicken abdominal preadipocytes was significantly increased by ACSL1 overexpression and significantly decreased by ACSL1 interference (Fig. 9G and H). These results indicated that the ACSL1 gene could inhibit the proliferation of chicken abdominal preadipocytes by accelerating the cell cycle transition from G0/G1 to S phase and S to G2/M phase as well as the intracellular glucose uptake capacity of chicken abdominal preadipocytes.

Fig. 9 — Effects of *ACSL1* gene expression on the proliferation of chicken abdominal preadipocytes. A and B CCK8 assay of *ACSL1*-overexpressing and -knockdown chicken abdominal preadipocytes. C and D Proliferation of *ACSL1*-overexpressing and -knockdown chicken abdominal preadipocytes determined by EdU assay. E and F Flow-cytometric cell cycle analysis of *ACSL1*-overexpressing and -knockdown chicken abdominal preadipocytes. G and H Glucose uptake capacity of *ACSL1*-overexpressing and -knockdown chicken abdominal preadipocytes. ^*P < 0.05, ^**P < 0.01

ACSL1 gene facilitates the adipogenic differentiation of chicken abdominal preadipocytes

To confirm whether ACSL1 regulates the adipogenic differentiation of chicken abdominal preadipocytes, we detected intracellular lipid droplet accumulation as well as intracellular triglyceride and acetyl-CoA levels via gain- and loss-of-function experiments in differentiated ICP2 cells. Excessive ACSL1 expression induced a significant increase in intracellular lipid droplet accumulation, as determined by Oil Red O and Nile red fluorescent staining assays (Fig. 10A–C). Moreover, intracellular triglyceride and acetyl-CoA levels were significantly increased upon ACSL1 stimulation (Fig. 10D and E). Accordingly, intracellular lipid droplet accumulation and triglyceride and acetyl-CoA levels were significantly lower in the siACSL1 knockdown group than in the siNC control group (Fig. 10F–J). These results indicate that ACSL1 facilitates the adipogenic differentiation of abdominal preadipocytes in chickens.

Fig. 10 — Effects of *ACSL1* gene expression on the adipogenic differentiation of chicken abdominal preadipocytes. A and B Representative images of Oil Red O staining and Nile red fluorescent staining of *ACSL1*-overexpressing differentiated chicken abdominal adipocytes. C Detection of the lipid droplet content of *ACSL1*-overexpressing differentiated chicken abdominal adipocytes. D and E Intracellular triglyceride and acetyl-CoA levels of *ACSL1*-overexpressing differentiated chicken abdominal adipocytes. F and G Representative images of Oil Red O staining and Nile red fluorescent staining of *ACSL1*-knockdown differentiated chicken abdominal adipocytes. H Detection of the lipid droplet content of *ACSL1*-knockdown differentiated chicken abdominal adipocytes. I and J Intracellular triglyceride and acetyl-CoA levels of *ACSL1*-knockdown differentiated chicken abdominal adipocytes. ^*P < 0.05, ^**P < 0.01

CircDOCK7 augments adipogenesis via acting as a ceRNA of gga-miR-301b-3p to activate the ACSL1 gene

Based on the interaction of gga-miR-301b-3p with circDOCK7 and ACSL1, we suggested that circDOCK7 might affect the abdominal adipogenesis via severing as a “miRNA sponge” of gga-miR-301b-3p to regulate the ACSL1 gene in chickens. To verify this, ICP2 cells were co-transfected with siNC + antagomir NC, siNC + miR-301b-3p antagomir, sicircDOCK7 + antagomir NC, and sicircDOCK7 + miR-301b-3p antagomir. At 48 h post-transfection, we determined ACSL1 mRNA expression and found that the miR-301b-3p antagomir-induced increase in ACSL1 mRNA expression was rescued by circDOCK7 knockdown, and the inhibitory role of circDOCK7 knockdown on ACSL1 mRNA expression was alleviated by miR-301b-3p antagomir (Fig. 11A), indicating that circDOCK7 could act as a ceRNA of gga-miR-301b-3p to post-transcriptionally regulate the downstream target ACSL1. Subsequently, we analyzed the cell proliferation of chicken abdominal preadipocytes and found that it was significantly suppressed by circDOCK7 knockdown, as evidenced by the CCK8 and EdU assays, which was abolished after supplemental treatment with gga-miR-301b-3p antagomir. Additionally, the gga-miR-301b-3p-silence-mediated promotion of the proliferation of chicken abdominal preadipocytes was abrogated following supplemental circDOCK7 knockdown (Fig. 11B–D).

Fig. 11 — circDOCK7 augments adipogenesis in a gga-miR-301b-3p-dependent manner. A Relative expression of the *ACSL1* gene in proliferative chicken abdominal preadipocytes co-transfected with sicircDOCK7 and miR-301b-3p antagomir. The relative gene expression levels are shown as fold changes compared with that in the siNC + antagomir NC group. B–D CCK8 and EdU staining assays in proliferative chicken abdominal preadipocytes co-transfected with sicircDOCK7 and miR-301b-3p antagomir. E Relative expression of the *ACSL1* gene in differentiated chicken abdominal preadipocytes co-transfected with circDOCK7 overexpression vector and miR-301b-3p agomir. The relative gene expression levels are shown as fold changes compared with that in the pLC5-ciR + agomir NC group. F–H Intracellular lipid droplet accumulation and triglyceride and acetyl-CoA levels in differentiated chicken abdominal adipocytes co-transfected with circDOCK7 overexpression vector and miR-301b-3p agomir. ^*P < 0.05, ^**P < 0.01. ^a–cMeans with different lowercase letters indicate significant difference (P < 0.05)

ICP2 cells were co-transfected with pLC5-ciR + miR-301b-3p agomir NC, pLC5-ciR + miR-301b-3p agomir, oe-circDOCK7 + miR-301b-3p agomir NC, and oe-circDOCK7 + miR-301b-3p agomir. At 48 h post-transfection, we detected ACSL1 mRNA expression and found that circDOCK7 overexpression promoted ACSL1 mRNA expression in differentiated chicken abdominal preadipocytes, whereas this effect was abolished by miR-301b-3p agomir. In addition, the suppression of ACSL1 mRNA expression caused by the miR-301b-3p agomir was rescued by circDOCK7 overexpression (Fig. 11E). Meanwhile, circDOCK7 overexpression reversed miR-301b-3p overexpression-mediated inhibition of intracellular lipid droplet accumulation as well as reduction in intracellular triglyceride and acetyl-CoA levels, and vice versa (Fig. 11F–H). Taken together, these results illustrate that the gga-miR-301b-3p/ACSL1 axis is required for the function of circDOCK7, and circDOCK7 could augment chicken abdominal adipogenesis in vitro by acting as a ceRNA, competitively adsorbing gga-miR-301b-3p to sequester it away from the ACSL1 gene, thus post-transcriptionally activating ACSL1 gene expression.

Discussion

Abnormal or excessive abdominal fat deposition is of tremendous concern owing to the worldwide prevalence of obesity and obesity-associated escalating health burdens, such as type 2 diabetes, dyslipidemia, hypertension, cardiovascular disease, and even cancers. In commercial broilers, abdominal fat is an imperative carcass trait, and its excessive accumulation is often discarded as a waste of feed energy, which increases their tendency toward physiological disorders and presents an obstacle to profitable farming. Despite substantial research efforts aimed at characterizing the genetic regulation of obesity and adipogenesis, the molecular mechanisms underlying abdominal fat deposition remain largely unknown in mammals and economically important agricultural avian species, especially chickens. CircRNAs are ubiquitous across eukaryotes and have been increasingly implicated as master regulators of mammalian adipogenesis [41, 42]. A number of circRNAs have been reported to share high evolutionary conservation among closely related species, even distantly related species [43]. Chicken (Gallus gallus) has been used as a good biomedical model organism to study the basic mechanisms of adipogenesis, obesity, and obesity-related diseases [44] and is suitable for investigating the circRNA-mediated biological functions and regulatory mechanisms underlying adipogenesis, which can produce useful comparative information for human obesity studies and also provide a promising biomarker associated with abdominal fat deposition for lean-line broiler breeding.

Abdominal fat deposition depends on the proliferation of preadipocytes and their maturation into adipocytes, during which an increase in lipid (mainly triglycerides) synthesis in adipocytes is a hallmark of adipogenic differentiation compared to preadipocytes. Our previous study based on circRNA sequencing found that circRNAs were abundant and dynamically expressed during abdominal preadipocyte differentiation in chickens [27]. Among these, an exonic circRNA, circDOCK7, exhibited a gradual increase in expression in abdominal adipocytes at different adipogenic differentiation stages, suggesting that circDOCK7 may play a crucial role in the positive regulation of adipogenesis in chickens. Backsplicing junction verification, RNase R treatment, and actinomycin D treatment confirmed that circDOCK7 is more stable than its linear counterpart, in agreement with the circular characteristics of circRNAs owing to their closed-loop structure, RNA exonuclease resistance, and longer half-lives [6, 45]. Our expression pattern analysis also demonstrated that circDOCK7 exhibited an overall increase in expression during the proliferation and differentiation of chicken abdominal preadipocytes. Moreover, circDOCK7 was most abundantly expressed and significantly upregulated in the abdominal fat tissues of chickens with a high abdominal fat percentage compared to that of chickens with a low abdominal fat percentage. Consistent with this, our in vitro gain- and loss-of-function experiments confirmed that circDOCK7 not only enhanced the proliferation of chicken abdominal preadipocytes, but also increased adipocyte lipid droplet accumulation and triglyceride, and acetyl-CoA content, in parallel with the mRNA abundance of PPARγ and CEBPα, two crucial determinants necessary and sufficient for adipocyte differentiation [46]. These results indicate that circDOCK7 serves as an accelerator of adipogenesis, resulting in the proliferation and differentiation of abdominal preadipocytes in chickens.

Once produced, circRNAs are either released into the cytoplasm or retained inside the nucleus, and exonic circRNAs predominantly localize to the cytoplasm [47]. Consistent with this, circDOCK7 is an exonic circRNA harboring three exons derived from DOCK7 and is mainly located in the cytoplasm of chicken abdominal preadipocytes. It has been proposed that the back-splicing of exons could compete against linear mRNA splicing during transcription; therefore, exonic circRNA biogenesis can completely alter the expression of their linear gene product [48]. Recent studies have also demonstrated the activity of some exonic circRNAs as protein recruiters that recruit specific proteins to certain loci or subcellular compartments, eventually influencing gene expression [49]. A case in point is that a novel circular RNA consisting of exons 4–2-3 of the friend leukemia virus integration 1 (FLI1) gene, referred to as FECR1, could recruit ten-eleven translocation methylcytosine dioxygenase 1 (TET1), a demethylase that is actively involved in DNA demethylation, to the promoter region of its host FLI1 gene, leading to DNA hypomethylation of CpG islands and active cis transcription of the FLI1 gene, thus regulating the metastasis of breast cancer cells [50]. CircDOCK7 is derived from the backsplicing of exons 19–22 of its parental DOCK7 gene. DOCK7 gene encoded a guanine nucleotide exchange factor for the Rho family of GTPases and has been used for type 2 diabetic obese model mice [51]. It was reported that DOCK7 gene polymorphism was dramatically associated with serum lipid levels including triglyceride, total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B in humans [52, 53]. In the present study, the DOCK7 gene exhibited no significant change during adipogenic differentiation of chicken abdominal preadipocytes according to our published RNA sequencing data (accession number: PRJNA732104) [27]. There is no significant expression correlation between the expression levels of circDOCK7 and DOCK7 gene during adipogenic differentiation of chicken abdominal preadipocytes. Importantly, the DOCK7 expression levels were not significantly changed upon circDOCK7 overexpression or knockdown in either proliferative or differentiated chicken abdominal preadipocytes. Taken together, these results suggest almost no potential for impairing circDOCK7 on chicken abdominal adipogenesis by transcriptional regulation of its parental DOCK7 gene, at least via competition with linear splicing and protein recruitment.

Although circRNAs were originally believed to be untranslatable owing to their lack of essential elements containing a 5′ cap and 3’ poly(A) tail for canonical cap-dependent translation initiation, it has been reported that some exonic circRNAs are equipped with an ORF. Accumulating evidence has shown that circRNAs are associated with ribosomes, confirming the authenticity of circRNA-translated functional peptides or proteins in mammalian cells [49, 54]. The translation of circRNAs is driven by an IRES element, which is a cis-acting RNA sequence, or m⁶A RNA modification, which is a post-transcriptional methylation modification that involves the addition of a methyl group to the N6 position of RNA adenosine, both of which can recruit the internal entry of small ribosomal subunits in eukaryotic cells to initiate translation [55]. To explore whether circDOCK7 can be translated into peptides or proteins, we carried out a bioinformatics analysis of ORF, IRES elements, and m⁶A modification based on the circDOCK7 sequence. However, despite the presence of an IRES element and two m⁶A modification sites, no ORF was detected in the sequence of circDOCK7, leading us to speculate that circDOCK7 has almost no translational capacity.

In addition, extensive evidence has supported the ceRNA hypothesis that cytoplasmic exonic circRNAs function as miRNA sponges or decoys that competitively adsorb miRNAs to protect target mRNAs from miRNA-dependent degradation, thereby modulating post-transcriptional regulation in various biological processes. miRNAs constitute a subclass of 18–25-nucleotide endogenous single-stranded non-coding RNAs and have been implicated in the regulation of mammalian and avian adipogenesis, thereby gaining prominence as key oncogenic drivers [56, 57]. Some circRNAs have been reported to act as miRNA sponges that participate in mammalian adipogenesis, such as circSAMD4A [14], CDR1as [16], circFUT10 [58], sus_circPAPPA2 [19] and circPPARA [20]. CircRNAs were indeed expressed in abdominal fat tissues and adipocytes, and the ceRNA network comprising circRNAs, miRNAs, and mRNAs indicated that circRNAs may play regulatory roles in abdominal adipogenesis by interacting with one or more miRNAs to prevent them from executing their regulatory roles [24–27]. A sequence analysis revealed the presence of multiple predicted miRNA response elements in circDOCK7, which inspired us to explore the ceRNA regulatory mechanism of circDOCK7 underlying chicken abdominal fat deposition. Among these, gga-miR-301b-3p was validated as directly binding to circDOCK7 based on a pull-down assay and a dual-luciferase reporter assay. Moreover, circDOCK7 knockdown remarkably upregulated gga-miR-301b-3p expression in proliferative and differentiated chicken abdominal preadipocytes, confirming that circDOCK7 serves as a molecular sponge to adsorb gga-miR-301b-3p. The seed region of gga-miR-301b-3p is conserved among human, mouse, chimp, pig and cow, indicating a similar contribution to adipogenesis in mammals and chickens. In this study, gga-miR-301b-3p was significantly downregulated in abdominal fat tissues and showed an overall decreased expression level following the proliferation and adipogenic differentiation of chicken abdominal preadipocytes, which was strongly negatively correlated with circDOCK7, suggesting the involvement of gga-miR-301b-3p in abdominal adipogenesis in chickens. In this study, we demonstrated that chicken abdominal preadipocyte proliferation, adipocyte lipid droplet accumulation, and triglyceride and acetyl-CoA content were significantly decreased upon gga-miR-301b-3p stimulation but significantly increased upon gga-miR-301b-3p silencing, demonstrating that gga-miR-301b-3p served as an inhibitor of adipogenesis in chickens, in contrast to the role of circDOCK7. Strikingly, these inhibitory effects of gga-miR-301b-3p on the proliferation and adipogenic differentiation of chicken abdominal preadipocytes could be relieved by circDOCK7, and thus the enhanced effects of circDOCK7 could be abolished by miR-301b-3p. These results further suggested that circDOCK7 could serve as a modulator of abdominal adipogenesis by sponging gga-miR-301b-3p in chickens.miRNAs function as regulatory molecules that recognize 3′ UTRs of protein-coding genes to post-transcriptionally trigger their cleavage or translational repression [59]. Therefore, we predicted major targets of gga-miR-301b-3p and confirmed ACSL1 gene as a direct target of gga-miR-301b-3p. Meanwhile, ACSL1 mRNA abundance was suppressed by gga-miR-301b-3p overexpression and enhanced by gga-miR-301b-3p knockdown. Strikingly, the inhibitory effects of gga-miR-301b-3p on the post-transcriptional expression of ACSL1 were relieved by circDOCK7 in both proliferative and differentiated chicken abdominal preadipocytes, and the above-mentioned promoted role of circDOCK7 in ACSL1 mRNA expression was abolished by gga-miR-301b-3p, indicating that circDOCK7 could serve as a ceRNA to sponge gga-miR-301b-3p and prevent ACSL1 gene from gga-miR-301b-3p-mediated mRNA degradation, thereby post-transcriptionally upregulating ACSL1 expression. Notably, the ACSL1 gene belongs to the ACSL gene family that is responsible for catalyzing the conversion of exogenous or endogenous long-chain fatty acids by adipose cells into acyl coenzyme A (acyl-CoA), which undergoes β-oxidation in the mitochondrial matrix for the formation of acetyl-CoA, a raw lipid synthesis precursor that can then be incorporated into triglycerides, phospholipids, and cholesteryl esters, and has been proven to be at the critical juncture of de novo lipid synthesis and β-oxidation degradation [60]. ACSL1 has been identified as a dominant ACSL isoform, owing to its 80% contribution to the total ACSL activity in the adipose tissue, and preferentially utilizes palmitoleate, oleate, and linoleate as substrates [61, 62]. The ACSL1 gene showed the highest mRNA abundance in adipose tissue of mammals and Chinese indigenous Lushi blue-shell-egg chickens [63], which is in agreement with the finding of our present study that ACSL1 is most abundantly expressed in the adipose tissue of commercial broilers. In addition, in vivo and in vitro expression patterns showed a noteworthy increase in ACSL1 gene expression in the abdominal fat of chickens with high abdominal fat percentage and during the proliferation and adipogenic differentiation of chicken abdominal preadipocytes in a time-dependent manner. Moreover, ACSL1 has been reported to be localized in the mitochondrial membrane, plasma membrane, and endoplasmic reticulum of mammalian adipocytes [64]. The endoplasmic reticulum is a major “lipid factory” organelle where lipids are synthesized, assembled, and transported. Mitochondria are crucial sites for free fatty acid β-oxidation and glycolysis and can import certain proteins and lipids to maintain cell survival [65]. Our subcellular localization analysis also showed that chicken ACSL1 was localized in the endoplasmic reticulum and mitochondria in chicken abdominal preadipocytes. Functionally, the adipose-specific ACSL1 knockout mice exhibited a 50%–90% lower fatty acid oxidation rate in adipocytes isolated than that in control adipocytes [61]. In adipocytes differentiated from mesenchymal stem cells of neonates born small for gestational age, both the mRNA and protein abundance of the ACSL1 gene consistently increased during adipogenesis, in parallel with enhanced glucose uptake and total lipid content, and ACSL1 deficiency impeded lipid loading and reduced glucose uptake [66]. Despite this evidence concerning the importance of ACSL1 in mammalian adipogenesis, little is known about the role of ACSL1 in avian adipogenesis. Consequently, we first detected the effects of ACSL1 gene on the proliferation and adipogenic differentiation of chicken abdominal preadipocytes using gain- and loss-of-function assays and found that the overexpression of ACSL1 gene contributed to a significant increase in proliferation concomitant with their maturation into adipocytes, characterized by increased intracellular lipid droplet accumulation and triglyceride and acetyl-CoA levels, and vice versa. During cell proliferation, proliferating cells often display enhanced uptake of glucose, an energy source for ATP generation, as well as an important carbon source to support the production of lipids and biosynthesis of nucleotides and non-essential amino acids to produce daughter cells. Heavy consumption of glucose is essential for nucleotide biosynthesis and successful replicative cell division for cancer cell growth [67]. It has been reported that low glucose could induce cell cycle G1 arrest to inhibit the proliferation of human endometrial cancer cell lines [68]. Likewise, our results showed that ACSL1 improved the glucose uptake capacity of proliferating chicken abdominal preadipocytes. Therefore, we concluded that the ACSL1 gene could serve as a fundamental contributing factor in abdominal fat deposition by facilitating the proliferation, at least by promoting glucose uptake capacity, and adipogenic differentiation of abdominal preadipocytes in chickens.

New insights have been gained regarding the direct RNA-RNA interactome mediated by circRNAs to regulate the biogenesis and function of RNA molecules other than miRNAs, such as long non-coding RNAs and mRNAs, to influence their stability, translation, and localization [69]. A recent study concerning the interaction of exonic circRNA with mRNA reported that loop-hairpins were required for the circRNA-mRNA interactome, and an immune cell-associated circRNA circPan3 could promote the mRNA expression of the interleukin 13 receptor subunit alpha 1 (IL-13Rα1) gene upon facilitation of its mRNA stability through direct interaction with IL-13Rα1 mRNA [70]. RNA secondary structure prediction based on the circDOCK7 sequence showed that circDOCK7 also has a loop-hairpin structure. Therefore, we speculated that circDOCK7 might directly interact with key genes involved in lipid metabolism to modulate their stability, localization, and/or expression, and consequently regulate abdominal fat deposition in chickens, which needs to be further investigated.

Conclusions

In conclusion, a cytoplasmic exonic circDOCK7 could function as a miRNA sponge that directly sequesters gga-miR-301b-3p away from the ACSL1 gene to post-transcriptionally promote ACSL1 mRNA expression, subsequently facilitating the proliferation and differentiation of abdominal preadipocytes in chickens (Fig. 12). To the best of our knowledge, this is the first study to provide strong evidence that circRNAs involved in abdominal fat deposition act as miRNA sponges in chickens, shedding new light on regulatory mechanisms in avian adipogenesis.

Fig. 12 — Proposed model for the regulatory mechanism of circDOCK7 in chicken abdominal adipogenesis. CircDOCK7 is a new adipogenesis-stimulating circRNA in chickens. CircDOCK7 serves as a ceRNA to modulate the gga-miR-301b-3p/*ACSL1* axis, thus promoting the proliferation and adipogenic differentiation of chicken abdominal preadipocytes

Supplementary Information

40104_2023_891_MOESM1_ESM.docx^{(21.4KB, docx)}

Additional file 1: Table S1. Primer information used in this study. Table S2. Sequences of circDOCK7 transcripts.

40104_2023_891_MOESM2_ESM.docx^{(14.5MB, docx)}

Additional file 2: Fig. S1. Predicted secondary structure of circDOCK7. Fig. S2. Effects of circDOCK7 overexpression on the proliferation of chicken abdominal preadipocytes. Fig. S3. Prediction of m⁶A modification sites based on circDOCK7 sequence. Fig. S4. Effects of circDOCK7 on the expression of its parental DOCK7 gene. Fig. S5. CircDOCK7-mediated potential ceRNA regulation during the adipogenic differentiation of chicken abdominal preadipocytes. Fig. S6. Prediction of subcellular localization of chicken ACSL1 protein using UniProt.

Acknowledgements

We thank both Dr. Hui Li and Dr. Ning Wang of Northeast Agricultural University for providing the cell lines in this study.

Abbreviations

Acetyl-CoA: Acetyl coenzyme A
ACSL1: Acyl-CoA synthetase long-chain family member 1
CCK8: Cell Counting Kit-8
cDNA: Complementary DNA
CEBPα: CCAAT/enhancer-binding protein alpha
ceRNA: Competing endogenous RNA
CircRNA: Circular RNA
DMEM-F12: Dulbecco’s modified Eagle’s medium F12
DOCK7: Dedicator of cytokinesis 7
EdU: 5-Ethynyl-2-deoxyuridine
ER: Endoplasmic reticulum
FBS: Fetal bovine serum
gDNA: Genomic DNA
HAbF: High abdominal fat percentage
ICP2: Immortalized chicken preadipocytes 2
IRES: Internal ribosome entry site
LAbF: Low abdominal fat percentage
miRNAs: MicroRNAs
MT: Mitochondria
ORFs: Open reading fragments
PPARγ: Peroxisome proliferator activated receptor gamma
qRT-PCR: Quantitative real-time PCR
TG: Triglycerides
3' UTR: 3' Untranslated region

Authors’ contributions

WHT performed the experiments and prepared the manuscript. YL helped to perform the cell culture and treatment experiments. WHZ and RXN collected the samples and analyzed the data. BZ and YL visualized the results and helped with manuscript revision. HZ participated in the design of the study, supervised the project, and revised the manuscript. CXW conceived the study and provided overall supervision. All authors read and approved the final manuscript.

Funding

This research was supported by the National Key Research and Development Program of China (2021YFD1200803 and 2022YFD1600902) and China Agriculture Research System (CARS-40).

Availability of data and material

The data for the current study are available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Contributor Information

Weihua Tian, Email: tianweihua126@126.com.

Ye Liu, Email: liuye2019@outlook.com.

Wenhui Zhang, Email: mx120170643@yzu.edu.cn.

Ruixue Nie, Email: nrx_grit9@163.com.

Yao Ling, Email: lingzi@cau.edu.cn.

Bo Zhang, Email: bozhang0606@cau.edu.cn.

Hao Zhang, Email: hzhang@cau.edu.cn.

Changxin Wu, Email: chxwu@cau.edu.cn.

References

1.Zhang XY, Wu MQ, Wang SZ, Zhang H, Du ZQ, Li YM, et al. Genetic selection on abdominal fat content alters the reproductive performance of broilers. Animal. 2018;12(6):1232–1241. doi: 10.1017/S1751731117002658. [DOI] [PubMed] [Google Scholar]
2.Geraert PA, MacLeod MG, Larbier M, Leclercq B. Nitrogen metabolism in genetically fat and lean chickens. Poult Sci. 1990;69(11):1911–1921. doi: 10.3382/ps.0691911. [DOI] [PubMed] [Google Scholar]
3.Demeure O, Duclos MJ, Bacciu N, Le Mignon G, Filangi O, Pitel F, et al. Genome-wide interval mapping using SNPs identifies new QTL for growth, body composition and several physiological variables in an F2 intercross between fat and lean chicken lines. Genet Sel Evol. 2013;45(1):36. doi: 10.1186/1297-9686-45-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Cahaner A, Nitsan Z. Evaluation of simultaneous selection for live body weight and against abdominal fat in broilers. Poult Sci. 1985;64(7):1257–1263. doi: 10.3382/ps.0641257. [DOI] [PubMed] [Google Scholar]
5.Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi: 10.1080/15476286.2015.1020271. [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34(8):e63. doi: 10.1093/nar/gkl151. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi: 10.1038/s41576-019-0158-7. [DOI] [PubMed] [Google Scholar]
8.Xia S, Feng J, Lei L, Hu J, Xia L, Wang J, et al. Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes. Brief Bioinform. 2017;18(6):984–992. doi: 10.1093/bib/bbw081. [DOI] [PubMed] [Google Scholar]
9.Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777. doi: 10.1371/journal.pgen.1003777. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Veno MT, Hansen TB, Veno ST, Clausen BH, Grebing M, Finsen B, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol. 2015;16:245. doi: 10.1186/s13059-015-0801-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045. doi: 10.1080/15476286.2016.1271524. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther. 2018;187:31–44. doi: 10.1016/j.pharmthera.2018.01.010. [DOI] [PubMed] [Google Scholar]
13.Arcinas C, Tan W, Fang WN, Desai TP, Teh DCS, Degirmenci U, et al. Adipose circular RNAs exhibit dynamic regulation in obesity and functional role in adipogenesis. Nat Metab. 2019;1(7):688–703. doi: 10.1038/s42255-019-0078-z. [DOI] [PubMed] [Google Scholar]
14.Liu Y, Liu H, Li Y, Mao R, Yang H, Zhang Y, et al. Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis. Theranostics. 2020;10(10):4705–4719. doi: 10.7150/thno.42417. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Cherubini A, Barilani M, Rossi RL, Jalal MMK, Rusconi F, Buono G, et al. FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition. Nucleic Acids Res. 2019;47(10):5325–5340. doi: 10.1093/nar/gkz199. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Chen G, Wang Q, Li Z, Yang Q, Liu Y, Du Z, et al. Circular RNA CDR1as promotes adipogenic and suppresses osteogenic differentiation of BMSCs in steroid-induced osteonecrosis of the femoral head. Bone. 2020;133:115258. doi: 10.1016/j.bone.2020.115258. [DOI] [PubMed] [Google Scholar]
17.Zhu Y, Gui W, Lin X, Li H. Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1. Exp Cell Res. 2020;387(2):111753. doi: 10.1016/j.yexcr.2019.111753. [DOI] [PubMed] [Google Scholar]
18.Kang Z, Zhang S, Jiang E, Wang X, Wang Z, Chen H, et al. circFLT1 and lncCCPG1 sponges miR-93 to regulate the proliferation and differentiation of adipocytes by promoting lncSLC30A9 expression. Mol Ther Nucleic Acids. 2020;22:484–499. doi: 10.1016/j.omtn.2020.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
19.Liu X, Bai Y, Cui R, He S, Zhao X, Wu K, et al. Sus_circPAPPA2 regulates fat deposition in castrated pigs through the miR-2366/GK pathway. Biomolecules. 2022;12(6):753. doi: 10.3390/biom12060753. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Li B, He Y, Wu W, Tan X, Wang Z, Irwin DM, et al. Circular RNA profiling identifies novel circPPARA that promotes intramuscular fat deposition in pigs. J Agric Food Chem. 2022;70(13):4123–4137. doi: 10.1021/acs.jafc.1c07358. [DOI] [PubMed] [Google Scholar]
21.Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu K, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 2019;38(15):2844–2859. doi: 10.1038/s41388-018-0619-z. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
22.Zhang X, Chen L, Xiao B, Liu H, Su Y. Circ_0075932 in adipocyte-derived exosomes induces inflammation and apoptosis in human dermal keratinocytes by directly binding with PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB pathway. Biochem Biophys Res Commun. 2019;511(3):551–58. doi: 10.1016/j.bbrc.2019.02.082. [DOI] [PubMed] [Google Scholar]
23.Zhu M, Liu X, Li W, Wang L. Exosomes derived from mmu_circ_0000623-modified ADSCs prevent liver fibrosis via activating autophagy. Hum Exp Toxicol. 2020;39(12):1619–1627. doi: 10.1177/0960327120931152. [DOI] [PubMed] [Google Scholar]
24.Jin W, Zhao Y, Zhai B, Li Y, Fan S, Yuan P, et al. Characteristics and expression profiles of circRNAs during abdominal adipose tissue development in Chinese Gushi chickens. PLoS ONE. 2021;16(4):e0249288. doi: 10.1371/journal.pone.0249288. [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Zhang M, Han Y, Zhai Y, Ma X, An X, Zhang S, et al. Integrative analysis of circRNAs, miRNAs, and mRNAs profiles to reveal ceRNAs networks in chicken intramuscular and abdominal adipogenesis. BMC Genomics. 2020;21(1):594. doi: 10.1186/s12864-020-07000-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Xiao C, Sun T, Yang Z, Zou L, Deng J, Yang X. Whole-transcriptome RNA sequencing reveals the global molecular responses and circRNA/lncRNA-miRNA-mRNA ceRNA regulatory network in chicken fat deposition. Poult Sci. 2022;101(11):102121. doi: 10.1016/j.psj.2022.102121. [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Tian W, Zhang B, Zhong H, Nie R, Ling Y, Zhang H, et al. Dynamic expression and regulatory network of circular RNA for abdominal preadipocytes differentiation in chicken (Gallus gallus) Front Cell Dev Biol. 2021;9:761638. doi: 10.3389/fcell.2021.761638. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Tian WH, Hao X, Nie RX, Ling Y, Zhang B, Zhang H, et al. Integrative analysis of miRNA and mRNA profiles reveals that gga-miR-106–5p inhibits adipogenesis by targeting the KLF15 gene in chickens. J Anim Sci Biotechno. 2022;13(1):81. doi: 10.1186/s40104-022-00727-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
29.Busk PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinform. 2014;15:29. doi: 10.1186/1471-2105-15-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012;13(1):134. doi: 10.1186/1471-2105-13-134. [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008;36(Web Server issue):W70–4. doi: 10.1093/nar/gkn188. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000;16(6):276–277. doi: 10.1016/s0168-9525(00)02024-2. [DOI] [PubMed] [Google Scholar]
34.Zhao J, Wu J, Xu T, Yang Q, He J, Song X. IRESfinder: Identifying RNA internal ribosome entry site in eukaryotic cell using framed k-mer features. J Genet Genomics. 2018;45(7):403–406. doi: 10.1016/j.jgg.2018.07.006. [DOI] [PubMed] [Google Scholar]
35.Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91. doi: 10.1093/nar/gkw104. [DOI] [PMC free article] [PubMed] [Google Scholar]
36.Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10(10):1507–1517. doi: 10.1261/rna.5248604. [DOI] [PMC free article] [PubMed] [Google Scholar]
37.UniProt C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506–D515. doi: 10.1093/nar/gky1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36(suppl_1):D149–53. doi: 10.1093/nar/gkm995. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787–798. doi: 10.1016/s0092-8674(03)01018-3. [DOI] [PubMed] [Google Scholar]
40.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]
41.Zhang Y, Tian Z, Ye H, Sun X, Zhang H, Sun Y, et al. Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity. Cell Death Discov. 2022;8(1):268. doi: 10.1038/s41420-022-01062-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Wang F, Li X, Li Z, Wang S, Fan J. Functions of circular RNAs in regulating adipogenesis of mesenchymal stem cells. Stem Cells Int. 2020;2020:3763069. doi: 10.1155/2020/3763069. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Wu W, Ji P, Zhao F. CircAtlas: an integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes. Genome Biol. 2020;21(1):101. doi: 10.1186/s13059-020-02018-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Abdalla BA, Chen J, Nie QH, Zhang XQ. Genomic insights into the multiple factors controlling abdominal fat deposition in a chicken model. Front Genet. 2018;9:262. doi: 10.3389/fgene.2018.00262. [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi: 10.1261/rna.035667.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
46.Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab. 2009;20(3):107–114. doi: 10.1016/j.tem.2008.11.005. [DOI] [PubMed] [Google Scholar]
47.Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE. 2012;7(2):e30733. doi: 10.1371/journal.pone.0030733. [DOI] [PMC free article] [PubMed] [Google Scholar]
48.Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. CircRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi: 10.1016/j.molcel.2014.08.019. [DOI] [PubMed] [Google Scholar]
49.Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503. doi: 10.7150/thno.42174. [DOI] [PMC free article] [PubMed] [Google Scholar]
50.Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):218. doi: 10.1186/s13059-018-1594-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Kitada M, Ogura Y, Koya D. Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovasc Dis. 2016;9:279–290. doi: 10.2147/IJNRD.S103784. [DOI] [PMC free article] [PubMed] [Google Scholar]
52.Guo T, Yin RX, Huang F, Yao LM, Lin WX, Pan SL. Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels. Sci Rep. 2016;6(1):19079. doi: 10.1038/srep19079. [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47–55. doi: 10.1038/ng.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, et al. Translation of circRNAs. Mol Cell. 2017;66(1):9–21 e7. doi: 10.1016/j.molcel.2017.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
55.Kong S, Tao M, Shen X, Ju S. Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products. Cancer Lett. 2020;483:59–65. doi: 10.1016/j.canlet.2020.04.006. [DOI] [PubMed] [Google Scholar]
56.Gharanei S, Shabir K, Brown JE, Weickert MO, Barber TM, Kyrou I, et al. Regulatory microRNAs in brown, brite and white adipose tissue. Cells-Basel. 2020;9(11):2489. doi: 10.3390/cells9112489. [DOI] [PMC free article] [PubMed] [Google Scholar]
57.Nematbakhsh S, Pei Pei C, Selamat J, Nordin N, Idris LH, Abdull Razis AF. Molecular regulation of lipogenesis, adipogenesis and fat deposition in chicken. Genes (Basel) 2021;12(3):414. doi: 10.3390/genes12030414. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Jiang R, Li H, Yang J, Shen X, Song C, Yang Z, et al. CircRNA profiling reveals an abundant circFUT10 that promotes adipocyte proliferation and inhibits adipocyte differentiation via sponging let-7. Mol Ther Nucleic Acids. 2020;20:491–501. doi: 10.1016/j.omtn.2020.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi: 10.1016/s0092-8674(04)00045-5. [DOI] [PubMed] [Google Scholar]
60.Mashek DG, Li LO, Coleman RA. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol. 2007;2(4):465–476. doi: 10.2217/17460875.2.4.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
61.Ellis JM, Li LO, Wu P-C, Koves TR, Ilkayeva O, Stevens RD, et al. Adipose acyl-CoA synthetase-1 directs fatty acids toward β-Oxidation and is required for cold thermogenesis. Cell Metab. 2010;12(1):53–64. doi: 10.1016/j.cmet.2010.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
62.Iijima H, Fujino T, Minekura H, Suzuki H, Kang MJ, Yamamoto T. Biochemical studies of two rat acyl-CoA synthetases, ACS1 and ACS2. Eur J Biochem. 1996;242(2):186–190. doi: 10.1111/j.1432-1033.1996.0186r.x. [DOI] [PubMed] [Google Scholar]
63.Mashek DG, Li LO, Coleman RA. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J Lipid Res. 2006;47(9):2004–2010. doi: 10.1194/jlr.M600150-JLR200. [DOI] [PubMed] [Google Scholar]
64.Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res. 1999;40(5):881–892. doi: 10.1016/S0022-2275(20)32123-4. [DOI] [PubMed] [Google Scholar]
65.Flis VV, Daum G. Lipid transport between the endoplasmic reticulum and mitochondria. Cold Spring Harb Perspect Biol. 2013;5(6):a013235. doi: 10.1101/cshperspect.a013235. [DOI] [PMC free article] [PubMed] [Google Scholar]
66.Joseph R, Poschmann J, Sukarieh R, Too PG, Julien SG, Xu F, et al. ACSL1 is associated with fetal programming of insulin sensitivity and cellular lipid content. Mol Endocrinol. 2015;29(6):909–920. doi: 10.1210/me.2015-1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
67.Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–450. doi: 10.1038/s41580-019-0123-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Han J, Zhang L, Guo H, Wysham WZ, Roque DR, Willson AK, et al. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol. 2015;138(3):668–675. doi: 10.1016/j.ygyno.2015.06.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
69.Panda AC, Grammatikakis I, Munk R, Gorospe M, Abdelmohsen K. Emerging roles and context of circular RNAs. Wiley Interdiscip Rev RNA. 2017;8(2):e1386. doi: 10.1002/wrna.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
70.Zhu P, Zhu X, Wu J, He L, Lu T, Wang Y, et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3. Nat Immunol. 2019;20(2):183–194. doi: 10.1038/s41590-018-0297-6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

40104_2023_891_MOESM1_ESM.docx^{(21.4KB, docx)}

Additional file 1: Table S1. Primer information used in this study. Table S2. Sequences of circDOCK7 transcripts.

40104_2023_891_MOESM2_ESM.docx^{(14.5MB, docx)}

Data Availability Statement

The data for the current study are available from the corresponding author upon reasonable request.

[CR1] 1.Zhang XY, Wu MQ, Wang SZ, Zhang H, Du ZQ, Li YM, et al. Genetic selection on abdominal fat content alters the reproductive performance of broilers. Animal. 2018;12(6):1232–1241. doi: 10.1017/S1751731117002658. [DOI] [PubMed] [Google Scholar]

[CR2] 2.Geraert PA, MacLeod MG, Larbier M, Leclercq B. Nitrogen metabolism in genetically fat and lean chickens. Poult Sci. 1990;69(11):1911–1921. doi: 10.3382/ps.0691911. [DOI] [PubMed] [Google Scholar]

[CR3] 3.Demeure O, Duclos MJ, Bacciu N, Le Mignon G, Filangi O, Pitel F, et al. Genome-wide interval mapping using SNPs identifies new QTL for growth, body composition and several physiological variables in an F2 intercross between fat and lean chicken lines. Genet Sel Evol. 2013;45(1):36. doi: 10.1186/1297-9686-45-36. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR4] 4.Cahaner A, Nitsan Z. Evaluation of simultaneous selection for live body weight and against abdominal fat in broilers. Poult Sci. 1985;64(7):1257–1263. doi: 10.3382/ps.0641257. [DOI] [PubMed] [Google Scholar]

[CR5] 5.Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi: 10.1080/15476286.2015.1020271. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR6] 6.Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34(8):e63. doi: 10.1093/nar/gkl151. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR7] 7.Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi: 10.1038/s41576-019-0158-7. [DOI] [PubMed] [Google Scholar]

[CR8] 8.Xia S, Feng J, Lei L, Hu J, Xia L, Wang J, et al. Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes. Brief Bioinform. 2017;18(6):984–992. doi: 10.1093/bib/bbw081. [DOI] [PubMed] [Google Scholar]

[CR9] 9.Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777. doi: 10.1371/journal.pgen.1003777. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR10] 10.Veno MT, Hansen TB, Veno ST, Clausen BH, Grebing M, Finsen B, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol. 2015;16:245. doi: 10.1186/s13059-015-0801-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR11] 11.Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045. doi: 10.1080/15476286.2016.1271524. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR12] 12.Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther. 2018;187:31–44. doi: 10.1016/j.pharmthera.2018.01.010. [DOI] [PubMed] [Google Scholar]

[CR13] 13.Arcinas C, Tan W, Fang WN, Desai TP, Teh DCS, Degirmenci U, et al. Adipose circular RNAs exhibit dynamic regulation in obesity and functional role in adipogenesis. Nat Metab. 2019;1(7):688–703. doi: 10.1038/s42255-019-0078-z. [DOI] [PubMed] [Google Scholar]

[CR14] 14.Liu Y, Liu H, Li Y, Mao R, Yang H, Zhang Y, et al. Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis. Theranostics. 2020;10(10):4705–4719. doi: 10.7150/thno.42417. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR15] 15.Cherubini A, Barilani M, Rossi RL, Jalal MMK, Rusconi F, Buono G, et al. FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition. Nucleic Acids Res. 2019;47(10):5325–5340. doi: 10.1093/nar/gkz199. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR16] 16.Chen G, Wang Q, Li Z, Yang Q, Liu Y, Du Z, et al. Circular RNA CDR1as promotes adipogenic and suppresses osteogenic differentiation of BMSCs in steroid-induced osteonecrosis of the femoral head. Bone. 2020;133:115258. doi: 10.1016/j.bone.2020.115258. [DOI] [PubMed] [Google Scholar]

[CR17] 17.Zhu Y, Gui W, Lin X, Li H. Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1. Exp Cell Res. 2020;387(2):111753. doi: 10.1016/j.yexcr.2019.111753. [DOI] [PubMed] [Google Scholar]

[CR18] 18.Kang Z, Zhang S, Jiang E, Wang X, Wang Z, Chen H, et al. circFLT1 and lncCCPG1 sponges miR-93 to regulate the proliferation and differentiation of adipocytes by promoting lncSLC30A9 expression. Mol Ther Nucleic Acids. 2020;22:484–499. doi: 10.1016/j.omtn.2020.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR19] 19.Liu X, Bai Y, Cui R, He S, Zhao X, Wu K, et al. Sus_circPAPPA2 regulates fat deposition in castrated pigs through the miR-2366/GK pathway. Biomolecules. 2022;12(6):753. doi: 10.3390/biom12060753. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR20] 20.Li B, He Y, Wu W, Tan X, Wang Z, Irwin DM, et al. Circular RNA profiling identifies novel circPPARA that promotes intramuscular fat deposition in pigs. J Agric Food Chem. 2022;70(13):4123–4137. doi: 10.1021/acs.jafc.1c07358. [DOI] [PubMed] [Google Scholar]

[CR21] 21.Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu K, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 2019;38(15):2844–2859. doi: 10.1038/s41388-018-0619-z. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

[CR22] 22.Zhang X, Chen L, Xiao B, Liu H, Su Y. Circ_0075932 in adipocyte-derived exosomes induces inflammation and apoptosis in human dermal keratinocytes by directly binding with PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB pathway. Biochem Biophys Res Commun. 2019;511(3):551–58. doi: 10.1016/j.bbrc.2019.02.082. [DOI] [PubMed] [Google Scholar]

[CR23] 23.Zhu M, Liu X, Li W, Wang L. Exosomes derived from mmu_circ_0000623-modified ADSCs prevent liver fibrosis via activating autophagy. Hum Exp Toxicol. 2020;39(12):1619–1627. doi: 10.1177/0960327120931152. [DOI] [PubMed] [Google Scholar]

[CR24] 24.Jin W, Zhao Y, Zhai B, Li Y, Fan S, Yuan P, et al. Characteristics and expression profiles of circRNAs during abdominal adipose tissue development in Chinese Gushi chickens. PLoS ONE. 2021;16(4):e0249288. doi: 10.1371/journal.pone.0249288. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR25] 25.Zhang M, Han Y, Zhai Y, Ma X, An X, Zhang S, et al. Integrative analysis of circRNAs, miRNAs, and mRNAs profiles to reveal ceRNAs networks in chicken intramuscular and abdominal adipogenesis. BMC Genomics. 2020;21(1):594. doi: 10.1186/s12864-020-07000-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR26] 26.Xiao C, Sun T, Yang Z, Zou L, Deng J, Yang X. Whole-transcriptome RNA sequencing reveals the global molecular responses and circRNA/lncRNA-miRNA-mRNA ceRNA regulatory network in chicken fat deposition. Poult Sci. 2022;101(11):102121. doi: 10.1016/j.psj.2022.102121. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR27] 27.Tian W, Zhang B, Zhong H, Nie R, Ling Y, Zhang H, et al. Dynamic expression and regulatory network of circular RNA for abdominal preadipocytes differentiation in chicken (Gallus gallus) Front Cell Dev Biol. 2021;9:761638. doi: 10.3389/fcell.2021.761638. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR28] 28.Tian WH, Hao X, Nie RX, Ling Y, Zhang B, Zhang H, et al. Integrative analysis of miRNA and mRNA profiles reveals that gga-miR-106–5p inhibits adipogenesis by targeting the KLF15 gene in chickens. J Anim Sci Biotechno. 2022;13(1):81. doi: 10.1186/s40104-022-00727-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR29] 29.Busk PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinform. 2014;15:29. doi: 10.1186/1471-2105-15-29. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR30] 30.Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012;13(1):134. doi: 10.1186/1471-2105-13-134. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR31] 31.Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR32] 32.Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008;36(Web Server issue):W70–4. doi: 10.1093/nar/gkn188. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR33] 33.Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000;16(6):276–277. doi: 10.1016/s0168-9525(00)02024-2. [DOI] [PubMed] [Google Scholar]

[CR34] 34.Zhao J, Wu J, Xu T, Yang Q, He J, Song X. IRESfinder: Identifying RNA internal ribosome entry site in eukaryotic cell using framed k-mer features. J Genet Genomics. 2018;45(7):403–406. doi: 10.1016/j.jgg.2018.07.006. [DOI] [PubMed] [Google Scholar]

[CR35] 35.Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91. doi: 10.1093/nar/gkw104. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR36] 36.Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10(10):1507–1517. doi: 10.1261/rna.5248604. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR37] 37.UniProt C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506–D515. doi: 10.1093/nar/gky1049. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR38] 38.Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36(suppl_1):D149–53. doi: 10.1093/nar/gkm995. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR39] 39.Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787–798. doi: 10.1016/s0092-8674(03)01018-3. [DOI] [PubMed] [Google Scholar]

[CR40] 40.Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR41] 41.Zhang Y, Tian Z, Ye H, Sun X, Zhang H, Sun Y, et al. Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity. Cell Death Discov. 2022;8(1):268. doi: 10.1038/s41420-022-01062-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR42] 42.Wang F, Li X, Li Z, Wang S, Fan J. Functions of circular RNAs in regulating adipogenesis of mesenchymal stem cells. Stem Cells Int. 2020;2020:3763069. doi: 10.1155/2020/3763069. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR43] 43.Wu W, Ji P, Zhao F. CircAtlas: an integrated resource of one million highly accurate circular RNAs from 1070 vertebrate transcriptomes. Genome Biol. 2020;21(1):101. doi: 10.1186/s13059-020-02018-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR44] 44.Abdalla BA, Chen J, Nie QH, Zhang XQ. Genomic insights into the multiple factors controlling abdominal fat deposition in a chicken model. Front Genet. 2018;9:262. doi: 10.3389/fgene.2018.00262. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR45] 45.Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi: 10.1261/rna.035667.112. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR46] 46.Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab. 2009;20(3):107–114. doi: 10.1016/j.tem.2008.11.005. [DOI] [PubMed] [Google Scholar]

[CR47] 47.Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE. 2012;7(2):e30733. doi: 10.1371/journal.pone.0030733. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR48] 48.Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. CircRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi: 10.1016/j.molcel.2014.08.019. [DOI] [PubMed] [Google Scholar]

[CR49] 49.Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503. doi: 10.7150/thno.42174. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR50] 50.Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):218. doi: 10.1186/s13059-018-1594-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR51] 51.Kitada M, Ogura Y, Koya D. Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovasc Dis. 2016;9:279–290. doi: 10.2147/IJNRD.S103784. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR52] 52.Guo T, Yin RX, Huang F, Yao LM, Lin WX, Pan SL. Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels. Sci Rep. 2016;6(1):19079. doi: 10.1038/srep19079. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR53] 53.Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47–55. doi: 10.1038/ng.269. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR54] 54.Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, et al. Translation of circRNAs. Mol Cell. 2017;66(1):9–21 e7. doi: 10.1016/j.molcel.2017.02.021. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR55] 55.Kong S, Tao M, Shen X, Ju S. Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products. Cancer Lett. 2020;483:59–65. doi: 10.1016/j.canlet.2020.04.006. [DOI] [PubMed] [Google Scholar]

[CR56] 56.Gharanei S, Shabir K, Brown JE, Weickert MO, Barber TM, Kyrou I, et al. Regulatory microRNAs in brown, brite and white adipose tissue. Cells-Basel. 2020;9(11):2489. doi: 10.3390/cells9112489. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR57] 57.Nematbakhsh S, Pei Pei C, Selamat J, Nordin N, Idris LH, Abdull Razis AF. Molecular regulation of lipogenesis, adipogenesis and fat deposition in chicken. Genes (Basel) 2021;12(3):414. doi: 10.3390/genes12030414. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR58] 58.Jiang R, Li H, Yang J, Shen X, Song C, Yang Z, et al. CircRNA profiling reveals an abundant circFUT10 that promotes adipocyte proliferation and inhibits adipocyte differentiation via sponging let-7. Mol Ther Nucleic Acids. 2020;20:491–501. doi: 10.1016/j.omtn.2020.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR59] 59.Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi: 10.1016/s0092-8674(04)00045-5. [DOI] [PubMed] [Google Scholar]

[CR60] 60.Mashek DG, Li LO, Coleman RA. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol. 2007;2(4):465–476. doi: 10.2217/17460875.2.4.465. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR61] 61.Ellis JM, Li LO, Wu P-C, Koves TR, Ilkayeva O, Stevens RD, et al. Adipose acyl-CoA synthetase-1 directs fatty acids toward β-Oxidation and is required for cold thermogenesis. Cell Metab. 2010;12(1):53–64. doi: 10.1016/j.cmet.2010.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR62] 62.Iijima H, Fujino T, Minekura H, Suzuki H, Kang MJ, Yamamoto T. Biochemical studies of two rat acyl-CoA synthetases, ACS1 and ACS2. Eur J Biochem. 1996;242(2):186–190. doi: 10.1111/j.1432-1033.1996.0186r.x. [DOI] [PubMed] [Google Scholar]

[CR63] 63.Mashek DG, Li LO, Coleman RA. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J Lipid Res. 2006;47(9):2004–2010. doi: 10.1194/jlr.M600150-JLR200. [DOI] [PubMed] [Google Scholar]

[CR64] 64.Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res. 1999;40(5):881–892. doi: 10.1016/S0022-2275(20)32123-4. [DOI] [PubMed] [Google Scholar]

[CR65] 65.Flis VV, Daum G. Lipid transport between the endoplasmic reticulum and mitochondria. Cold Spring Harb Perspect Biol. 2013;5(6):a013235. doi: 10.1101/cshperspect.a013235. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR66] 66.Joseph R, Poschmann J, Sukarieh R, Too PG, Julien SG, Xu F, et al. ACSL1 is associated with fetal programming of insulin sensitivity and cellular lipid content. Mol Endocrinol. 2015;29(6):909–920. doi: 10.1210/me.2015-1020. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR67] 67.Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–450. doi: 10.1038/s41580-019-0123-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR68] 68.Han J, Zhang L, Guo H, Wysham WZ, Roque DR, Willson AK, et al. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol. 2015;138(3):668–675. doi: 10.1016/j.ygyno.2015.06.036. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR69] 69.Panda AC, Grammatikakis I, Munk R, Gorospe M, Abdelmohsen K. Emerging roles and context of circular RNAs. Wiley Interdiscip Rev RNA. 2017;8(2):e1386. doi: 10.1002/wrna.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR70] 70.Zhu P, Zhu X, Wu J, He L, Lu T, Wang Y, et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3. Nat Immunol. 2019;20(2):183–194. doi: 10.1038/s41590-018-0297-6. [DOI] [PubMed] [Google Scholar]

PERMALINK

CircDOCK7 facilitates the proliferation and adipogenic differentiation of chicken abdominal preadipocytes through the gga-miR-301b-3p/ACSL1 axis

Weihua Tian

Ye Liu

Wenhui Zhang

Ruixue Nie

Yao Ling

Bo Zhang

Hao Zhang

Changxin Wu

Abstract

Background

Results

Conclusions

Supplementary Information

Background

Methods

Ethics statement

Experimental animals and sample preparation

Cell culture and adipogenic differentiation

Complementary DNA (cDNA) synthesis and quantitative real-time PCR (qRT-PCR)

Cyclization validation of circDOCK7

Isolation of nuclear and cytoplasmic fractions

Fluorescence in situ hybridization (FISH)

Cell Counting Kit-8 (CCK-8) assay

5-Ethynyl‐2′‐deoxyuridine (EdU) assay

Cell cycle assay

Measurement of intracellular acetyl coenzyme A (acetyl-CoA) and triglycerides (TG)

Glucose uptake capacity assay

Oil Red O staining

Nile red fluorescent staining

Bioinformatics analysis

Construction of the ceRNA regulatory network

Plasmid construction and RNA oligonucleotide synthesis

Dual-luciferase reporter assay

RNA Pull-down assay

Statistical analysis

Results

Characterization and expression profile of circDOCK7

Fig. 1.

CircDOCK7 knockdown inhibits the proliferation of chicken abdominal preadipocytes

Fig. 2.

CircDOCK7 promotes the adipogenic differentiation of chicken abdominal preadipocytes

Fig. 3.

CircDOCK7 acts as a sponge for gga-miR-301b-3p to play biological roles

Fig. 4.

gga-miR-301b-3p inhibits the proliferation of chicken abdominal preadipocytes

Fig. 5.

gga-miR-301b-3p suppresses the adipogenic differentiation of chicken abdominal preadipocytes

Fig. 6.

ACSL1 is a direct target of gga-miR-301b-3p

Fig. 7.

Subcellular localization and expression profiles of chicken ACSL1 protein

Fig. 8.

ACSL1 gene facilitates proliferation and glucose uptake in chicken abdominal preadipocytes

Fig. 9.

ACSL1 gene facilitates the adipogenic differentiation of chicken abdominal preadipocytes

Fig. 10.

CircDOCK7 augments adipogenesis via acting as a ceRNA of gga-miR-301b-3p to activate the ACSL1 gene

Fig. 11.

Discussion

Conclusions

Fig. 12.

Supplementary Information

Acknowledgements

Abbreviations

Authors’ contributions

Funding

Availability of data and material

Declarations

Ethics approval and consent to participate

Consent for publication

Competing interests

Contributor Information

References

Associated Data

Supplementary Materials

Data Availability Statement

ACTIONS

PERMALINK